<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="es" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Arch Bronconeumol</journal-id><journal-id journal-id-type="iso-abbrev">Arch Bronconeumol</journal-id><journal-id journal-id-type="pmc-domain-id">3815</journal-id><journal-id journal-id-type="pmc-domain">pheelsevier</journal-id><journal-title-group><journal-title>Archivos De Bronconeumologia</journal-title></journal-title-group><issn pub-type="ppub">0300-2896</issn><issn pub-type="epub">1579-2129</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Elsevier - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7131716</article-id><article-id pub-id-type="pmcid-ver">PMC7131716.1</article-id><article-id pub-id-type="pmcaid">7131716</article-id><article-id pub-id-type="pmcaiid">7131716</article-id><article-id pub-id-type="doi">10.1016/S0300-2896(05)70731-6</article-id><article-id pub-id-type="pii">S0300-2896(05)70731-6</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Tratamiento Antimicrobiano</subject></subj-group></article-categories><title-group><article-title>Tratamiento antimicrobiano frente a la colonizaci&#243;n pulmonar por <italic toggle="yes">Pseudomonas aeruginosa</italic> en el paciente con fibrosis qu&#237;stica</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cant&#243;n</surname><given-names initials="R">R.</given-names></name><xref rid="aff1" ref-type="aff">a</xref><xref rid="cor1" ref-type="corresp">&#8270;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cobos</surname><given-names initials="N">N.</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>de Gracia</surname><given-names initials="J">J.</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baquero</surname><given-names initials="F">F.</given-names></name><xref rid="aff1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Honorato</surname><given-names initials="J">J.</given-names></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gartner</surname><given-names initials="S">S.</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>&#193;lvarez</surname><given-names initials="A">A.</given-names></name><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Salcedo</surname><given-names initials="A">A.</given-names></name><xref rid="aff4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Oliver</surname><given-names initials="A">A.</given-names></name><xref rid="aff5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Garc&#237;a-Quetglas</surname><given-names initials="E">E.</given-names></name><xref rid="aff3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><collab>en representaci&#243;n del Grupo Espa&#241;ol de Consenso del Tratamiento Antimicrobiano en el Paciente con Fibrosis Qu&#237;stica</collab><xref rid="fn1" ref-type="fn">*</xref></contrib><aff id="aff1"><label>a</label>Servicio de Microbiolog&#237;a. Hospital Universitario Ram&#243;n y Cajal. Madrid. Espa&#241;a</aff><aff id="aff2"><label>b</label>Unidad de Fibrosis Qu&#237;stica. Hospital Vall d&#8217;Hebron. Barcelona. Espa&#241;a</aff><aff id="aff3"><label>c</label>Servicio de Farmacolog&#237;a Cl&#237;nica. Cl&#237;nica Universitaria. Pamplona. Navarra. Espa&#241;a</aff><aff id="aff4"><label>d</label>Secci&#243;n de Neumolog&#237;a Pedi&#225;trica. Hospital Materno Infantil Universitario Gregorio Mara&#241;&#243;n. Madrid. Espa&#241;a</aff><aff id="aff5"><label>e</label>Servicio de Microbiolog&#237;a. Hospital Son Dureta. Palma de Mallorca. Espa&#241;a</aff></contrib-group><author-notes><corresp id="cor1"><label>&#8270;</label>Correspondencia: Dr. R. Cant&#243;n. Servicio de Microbiolog&#237;a. Hospital Universitario Ram&#243;n y Cajal. Ctra. Colmenar, km 9,100. 28034 Madrid. Espa&#241;a.</corresp><fn id="fn1"><label>*</label><p>Grupo Espa&#241;ol de Consenso del Tratamiento Antimicrobiano del Paciente con Fibrosis Qu&#237;stica, con participaci&#243;n de la Sociedad Espa&#241;ola de Fibrosis Qu&#237;stica (SEFQ): J. Dapena, L. M&#225;iz y C. V&#225;zquez; Sociedad Espa&#241;ola de Neumolog&#237;a Pedi&#225;trica (SENP): C. Antelo, N. Cobos, S. Gartner y A. Salcedo; Sociedad Espa&#241;ola de Enfermedades Infecciosas y Microbiolog&#237;a Cl&#237;nica (SEIMC): R. Cant&#243;n, L. Mart&#237;nez-Mart&#237;nez y A. Oliver; Sociedad Espa&#241;ola de Quimioterapia (SEQ): F. Baquero, E. Garc&#237;a-Quetglas y J. Honorato; Sociedad Espa&#241;ola de Neumolog&#237;a y Cirug&#237;a Tor&#225;cica (SEPAR): A. &#193;lvarez, L. Border&#237;as, J. de Gracia y M. Vendrell.</p></fn></author-notes><pub-date pub-type="ppub"><year>2005</year></pub-date><pub-date pub-type="epub"><day>6</day><month>1</month><year>2009</year></pub-date><volume>41</volume><issue-id pub-id-type="pmc-issue-id">355366</issue-id><fpage>1</fpage><lpage>25</lpage><pub-history><event event-type="pmc-release"><date><day>06</day><month>01</month><year>2009</year></date></event><event event-type="pmc-live"><date><day>08</day><month>04</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-09-18 23:25:21.303"><day>18</day><month>09</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2005 Sociedad Espa&#241;ola de Neumolog&#237;a y Cirug&#237;a Tor&#225;cica. Published by Elsevier Espa&#241;a S.L. All rights reserved.</copyright-statement><copyright-year>2005</copyright-year><copyright-holder>Sociedad Espa&#241;ola de Neumolog&#237;a y Cirug&#237;a Tor&#225;cica</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="main.pdf"/><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><back><ref-list><title>Bibliograf&#237;a</title><ref id="bib1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsui</surname><given-names>L.C.</given-names></name><name name-style="western"><surname>Buchwald</surname><given-names>M.</given-names></name><name name-style="western"><surname>Barker</surname><given-names>D.</given-names></name><name name-style="western"><surname>Braman</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Knowlton</surname><given-names>R.</given-names></name><name name-style="western"><surname>Schumm</surname><given-names>J.W.</given-names></name></person-group><article-title>Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker</article-title><source>Science</source><volume>29</volume><year>1985</year><fpage>1054</fpage><lpage>1057</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.2997931</pub-id><pub-id pub-id-type="pmid">2997931</pub-id></element-citation></ref><ref id="bib2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ratjen</surname><given-names>F.</given-names></name><name name-style="western"><surname>Doring</surname><given-names>G.</given-names></name></person-group><article-title>Cystic fibrosis</article-title><source>Lancet</source><volume>22</volume><year>2003</year><fpage>681</fpage><lpage>689</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(03)12567-6</pub-id><pub-id pub-id-type="pmid">12606185</pub-id></element-citation></ref><ref id="bib3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibson</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>B.W.</given-names></name></person-group><article-title>Pathophysiology and management of pulmonary infections in cystic fibrosis</article-title><source>Am J Respir Crit Care Med</source><volume>15</volume><year>2003</year><fpage>918</fpage><lpage>951</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200304-505SO</pub-id><pub-id pub-id-type="pmid">14555458</pub-id></element-citation></ref><ref id="bib4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andersen</surname><given-names>D.H.</given-names></name></person-group><article-title>Cystic fibrosis of the pancreas and its relation to celiac disease. A clinical and pathological study</article-title><source>Am J Dis Child</source><volume>56</volume><year>1938</year><fpage>344</fpage><lpage>399</lpage></element-citation></ref><ref id="bib5"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>P.A.</given-names></name></person-group><chapter-title>The epidemiology of cystic fibrosis</chapter-title><person-group person-group-type="editor"><name name-style="western"><surname>Hodson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Geddes</surname><given-names>D.M.</given-names></name></person-group><source>Cystic fibrosis</source><year>1995</year><publisher-name>Chapman &amp; Hall</publisher-name><publisher-loc>Londres</publisher-loc><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="bib6"><label>6.</label><mixed-citation publication-type="other">Cystic Fibrosis Foundation. Patient Registry 2001 Annual Data report. Bethesda: Cystic Fibrosis Foundation; 2002.</mixed-citation></ref><ref id="bib7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szaff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Flensborg</surname><given-names>E.W.</given-names></name></person-group><article-title>Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> infection</article-title><source>Acta Pediatr Scand</source><volume>72</volume><year>1983</year><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1651-2227.1983.tb09789.x</pub-id><pub-id pub-id-type="pmid">6637463</pub-id></element-citation></ref><ref id="bib8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lyczak</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Cannon</surname><given-names>C.L.</given-names></name><name name-style="western"><surname>Pier</surname><given-names>G.B.</given-names></name></person-group><article-title>Lung infection associated with cystic fibrosis</article-title><source>Clin Microbiol Rews</source><volume>15</volume><year>2002</year><fpage>194</fpage><lpage>222</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/CMR.15.2.194-222.2002</pub-id><pub-id pub-id-type="pmcid">PMC118069</pub-id><pub-id pub-id-type="pmid">11932230</pub-id></element-citation></ref><ref id="bib9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliver</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cant&#243;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Campo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Baquero</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bl&#225;zquez</surname><given-names>J.</given-names></name></person-group><article-title>High frequency of hypermutable <italic toggle="yes">Pseudomonas aeruginosa</italic> in cystic fibrosis lung infection</article-title><source>Science</source><volume>288</volume><year>2000</year><fpage>1251</fpage><lpage>1254</lpage><pub-id pub-id-type="pmid">10818002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.288.5469.1251</pub-id></element-citation></ref><ref id="bib10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name></person-group><article-title>Pulmonary infections in patients with cystic fibrosis</article-title><source>Semin Respir Infect</source><volume>17</volume><year>2002</year><fpage>47</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">11891518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/srin.2002.31690</pub-id></element-citation></ref><ref id="bib11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenfeld</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>R.L.</given-names></name></person-group><article-title><italic toggle="yes">Pseudomonas</italic> acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management</article-title><source>Curr Opin Pulm Med</source><volume>9</volume><year>2003</year><fpage>492</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">14534401</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00063198-200311000-00008</pub-id></element-citation></ref><ref id="bib12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emerson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rosenfeld</surname><given-names>M.</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>R.L.</given-names></name></person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic> and other predictors of mortality and morbidity in young children with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>34</volume><year>2002</year><fpage>91</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">12112774</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.10127</pub-id></element-citation></ref><ref id="bib13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Gracia</surname><given-names>J.</given-names></name><name name-style="western"><surname>&#193;lvarez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mata</surname><given-names>F.</given-names></name><name name-style="western"><surname>Guarner</surname><given-names>L.</given-names></name><name name-style="western"><surname>Vendrell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gartner</surname><given-names>S.</given-names></name></person-group><article-title>Fibrosis qu&#237;stica del adulto: estudio de 111 pacientes</article-title><source>Med Clin (Barc)</source><volume>119</volume><year>2002</year><fpage>605</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">12433335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0025-7753(02)73513-6</pub-id></element-citation></ref><ref id="bib14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donaldson</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>R.C.</given-names></name></person-group><article-title>Update on the pathogenesis of cystic fibrosis lung disease</article-title><source>Curr Opin Pulm Med</source><volume>9</volume><year>2003</year><fpage>486</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">14534400</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00063198-200311000-00007</pub-id></element-citation></ref><ref id="bib15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>J.J.</given-names></name><name name-style="western"><surname>Travis</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Greenberg</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>Welsh</surname><given-names>M.J.</given-names></name></person-group><article-title>Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid</article-title><source>Cell</source><volume>86</volume><year>1996</year><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">8612275</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0092-8674(00)81099-5</pub-id></element-citation></ref><ref id="bib16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brogden</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Ackermann</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>McCray</surname><given-names>P.B.</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Huttner</surname><given-names>K.M.</given-names></name></person-group><article-title>Differences in the concentrations of small, anionic, antimicrobial peptides in bronchoalveolar lavage fluid and in respiratory epithelia of patients with and without cystic fibrosis</article-title><source>Infect Immun</source><volume>67</volume><year>1999</year><fpage>4256</fpage><lpage>4259</lpage><pub-id pub-id-type="pmid">10417200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.67.8.4256-4259.1999</pub-id><pub-id pub-id-type="pmcid">PMC96733</pub-id></element-citation></ref><ref id="bib17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guggino</surname><given-names>W.B.</given-names></name></person-group><article-title>Cystic fibrosis salt/fluid controversy: in the thick of it</article-title><source>Nat Med</source><volume>7</volume><year>2001</year><fpage>888</fpage><lpage>889</lpage><pub-id pub-id-type="pmid">11479614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/90914</pub-id></element-citation></ref><ref id="bib18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pier</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Grout</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zaidi</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>L.G.</given-names></name><name name-style="western"><surname>Yankaskas</surname><given-names>J.R.</given-names></name></person-group><article-title>Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections</article-title><source>Science</source><volume>27</volume><year>1996</year><fpage>64</fpage><lpage>67</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.271.5245.64</pub-id><pub-id pub-id-type="pmcid">PMC3677515</pub-id><pub-id pub-id-type="pmid">8539601</pub-id></element-citation></ref><ref id="bib19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chmiel</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Berger</surname><given-names>M.</given-names></name><name name-style="western"><surname>Konstan</surname><given-names>M.W.</given-names></name></person-group><article-title>The role of inflammation in the pathophysiology of CF lung disease</article-title><source>Clin Rev Allergy Immunol</source><volume>23</volume><year>2002</year><fpage>5</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">12162106</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1385/CRIAI:23:1:005</pub-id></element-citation></ref><ref id="bib20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petersen</surname><given-names>N.T.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mordhorst</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Lind</surname><given-names>K.</given-names></name><name name-style="western"><surname>Flensborg</surname><given-names>E.W.</given-names></name><name name-style="western"><surname>Bruun</surname><given-names>B.</given-names></name></person-group><article-title>Respiratory infections in cystic fibrosis caused by virus, chlamydia and mycoplasma &#8211; Possible synergism with <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Acta Paediatr Scand</source><volume>70</volume><year>1981</year><fpage>623</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">6798822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1651-2227.1981.tb05757.x</pub-id></element-citation></ref><ref id="bib21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wat</surname><given-names>D.</given-names></name><name name-style="western"><surname>Doull</surname><given-names>I.</given-names></name></person-group><article-title>Respiratory virus infections in cystic fibrosis</article-title><source>Paediatr Respir Rev</source><volume>4</volume><year>2003</year><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">12880751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1526-0542(03)00059-9</pub-id></element-citation></ref><ref id="bib22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Yim</surname><given-names>D.</given-names></name><name name-style="western"><surname>Emerson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rosenfeld</surname><given-names>M.</given-names></name></person-group><article-title>Longitudinal assessment of <italic toggle="yes">Pseudomonas aeruginosa</italic> in young children with cystic fibrosis</article-title><source>J Infect Dis</source><volume>183</volume><year>2001</year><fpage>444</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">11133376</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/318075</pub-id></element-citation></ref><ref id="bib23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Speert</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Henry</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Milner</surname><given-names>R.</given-names></name><name name-style="western"><surname>Taha</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gravelle</surname><given-names>A.</given-names></name></person-group><article-title>Epidemiology <italic toggle="yes">of Pseudomonas aeruginosa</italic> in cystic fibrosis in British Columbia, Canada</article-title><source>Am J Respir Crit Care Med</source><volume>166</volume><year>2002</year><fpage>988</fpage><lpage>993</lpage><pub-id pub-id-type="pmid">12359659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.2203011</pub-id></element-citation></ref><ref id="bib24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Griese</surname><given-names>M.</given-names></name><name name-style="western"><surname>Muller</surname><given-names>I.</given-names></name><name name-style="western"><surname>Reinhardt</surname><given-names>D.</given-names></name></person-group><article-title>Eradication of initial <italic toggle="yes">Pseudomonas aeruginosa</italic> colonization in patients with cystic fibrosis</article-title><source>Eur J Med Res</source><volume>7</volume><year>2002</year><fpage>79</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">11891148</pub-id></element-citation></ref><ref id="bib25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenfeld</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gibson</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>S.</given-names></name><name name-style="western"><surname>Emerson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Castile</surname><given-names>R.</given-names></name></person-group><article-title>Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>32</volume><year>2001</year><fpage>356</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">11596160</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.1144</pub-id></element-citation></ref><ref id="bib26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Govan</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Deretic</surname><given-names>V.</given-names></name></person-group><article-title>Microbial pathogenesis in cystic fibrosis: mucoid <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Burkholderia cepacia</italic></article-title><source>Microbiol Rev</source><volume>60</volume><year>1996</year><fpage>539</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">8840786</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mr.60.3.539-574.1996</pub-id><pub-id pub-id-type="pmcid">PMC239456</pub-id></element-citation></ref><ref id="bib27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Renders</surname><given-names>N.</given-names></name><name name-style="western"><surname>Verbrugh</surname><given-names>H.</given-names></name><name name-style="western"><surname>Van Belkum</surname><given-names>A.</given-names></name></person-group><article-title>Dynamics of bacterial colonisation in the respiratory tract of patients with cystic fibrosis</article-title><source>Infect Genet Evol</source><volume>1</volume><year>2001</year><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">12798048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1567-1348(01)00004-1</pub-id></element-citation></ref><ref id="bib28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munck</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bonacorsi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mariani-Kurkdjian</surname><given-names>P.</given-names></name><name name-style="western"><surname>Lebourgeois</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gerardin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brahimi</surname><given-names>N.</given-names></name></person-group><article-title>Genotypic characterization of <italic toggle="yes">Pseudomonas aeruginosa</italic> strains recovered from patients with cystic fibrosis after initial and subsequent colonization</article-title><source>Pediatr Pulmonol</source><volume>32</volume><year>2001</year><fpage>288</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">11568989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.1121</pub-id></element-citation></ref><ref id="bib29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maselli</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Sontag</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Norris</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>MacKenzie</surname><given-names>T.</given-names></name><name name-style="western"><surname>Wagener</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>Accurso</surname><given-names>F.J.</given-names></name></person-group><article-title>Risk factors for initial acquisition of <italic toggle="yes">Pseudomonas aeruginosa</italic> in children with cystic fibrosis identified by newborn screening</article-title><source>Pediatr Pulmonol</source><volume>35</volume><year>2003</year><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">12629621</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.10230</pub-id></element-citation></ref><ref id="bib30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>West</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>B.L.</given-names></name><name name-style="western"><surname>Kosorok</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Laxova</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rock</surname><given-names>M.J.</given-names></name></person-group><article-title>Respiratory infections with <italic toggle="yes">Pseudomonas aeruginosa</italic> in children with cystic fibrosis: early detection by serology and assessment of risk factors</article-title><source>JAMA</source><volume>287</volume><year>2002</year><fpage>2958</fpage><lpage>2967</lpage><pub-id pub-id-type="pmid">12052125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.287.22.2958</pub-id></element-citation></ref><ref id="bib31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stutman</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Lieberman</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Nussbaum</surname><given-names>E.</given-names></name><name name-style="western"><surname>Marks</surname><given-names>M.I.</given-names></name></person-group><article-title>Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial</article-title><source>J Pediatr</source><volume>140</volume><year>2002</year><fpage>299</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">11953726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mpd.2002.121930</pub-id></element-citation></ref><ref id="bib32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kosorok</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Jalaluddin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Farrell</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>G.</given-names></name><name name-style="western"><surname>Colby</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Laxova</surname><given-names>A.</given-names></name></person-group><article-title>Comprehensive analysis of risk factors for acquisition of <italic toggle="yes">Pseudomonas aeruginosa</italic> in young children with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>26</volume><year>1998</year><fpage>81</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">9727757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1099-0496(199808)26:2&lt;81::aid-ppul2&gt;3.0.co;2-k</pub-id></element-citation></ref><ref id="bib33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abman</surname><given-names>S.H.</given-names></name><name name-style="western"><surname>Ogle</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Harbeck</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Butler-Simon</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hammond</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Accurso</surname><given-names>F.J.</given-names></name></person-group><article-title>Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening</article-title><source>J Pediatr</source><volume>119</volume><year>1991</year><fpage>211</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">1907318</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-3476(05)80729-2</pub-id></element-citation></ref><ref id="bib34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kosorok</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>L.</given-names></name><name name-style="western"><surname>West</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Rock</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Splaingard</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Laxova</surname><given-names>A.</given-names></name></person-group><article-title>Acceleration of lung disease in children with cystic fibrosis after <italic toggle="yes">Pseudomonas aeruginosa</italic> acquisition</article-title><source>Pediatr Pulmonol</source><volume>32</volume><year>2001</year><fpage>277</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">11568988</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.2009.abs</pub-id></element-citation></ref><ref id="bib35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aron</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Polla</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Bienvenu</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dall&#8217;ava</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dusser</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hubert</surname><given-names>D.</given-names></name></person-group><article-title>HLA class II polymorphism in cystic fibrosis. A possible modifier of pulmonary phenotype</article-title><source>Am J Respir Crit Care Med</source><volume>159</volume><year>1999</year><fpage>1464</fpage><lpage>1468</lpage><pub-id pub-id-type="pmid">10228112</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/ajrccm.159.5.9807046</pub-id></element-citation></ref><ref id="bib36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doring</surname><given-names>G.</given-names></name><name name-style="western"><surname>Krogh-Johansen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Weidinger</surname><given-names>S.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508</article-title><source>Ped Pulmonol</source><volume>18</volume><year>1994</year><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.1950180104</pub-id><pub-id pub-id-type="pmid">7970905</pub-id></element-citation></ref><ref id="bib37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loubieres</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Grenet</surname><given-names>D.</given-names></name><name name-style="western"><surname>Simon-Bouy</surname><given-names>B.</given-names></name><name name-style="western"><surname>Medioni</surname><given-names>J.</given-names></name><name name-style="western"><surname>Landais</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ferec</surname><given-names>C.</given-names></name></person-group><article-title>Association between genetically determined pancreatic status and lung disease in adult cystic fibrosis patients</article-title><source>Chest</source><volume>121</volume><year>2002</year><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">11796434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.121.1.73</pub-id></element-citation></ref><ref id="bib38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arkwright</surname><given-names>P.D.</given-names></name><name name-style="western"><surname>Laurie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Super</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pravica</surname><given-names>V.</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Webb</surname><given-names>A.K.</given-names></name></person-group><article-title>TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis</article-title><source>Thorax</source><volume>55</volume><year>2000</year><fpage>459</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">10817792</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thorax.55.6.459</pub-id><pub-id pub-id-type="pmcid">PMC1745768</pub-id></element-citation></ref><ref id="bib39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hull</surname><given-names>J.</given-names></name><name name-style="western"><surname>Thomson</surname><given-names>A.H.</given-names></name></person-group><article-title>Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis</article-title><source>Thorax</source><volume>53</volume><year>1998</year><fpage>1018</fpage><lpage>1021</lpage><pub-id pub-id-type="pmid">10195071</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.53.12.1018</pub-id><pub-id pub-id-type="pmcid">PMC1745152</pub-id></element-citation></ref><ref id="bib40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Mellis</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Petrovic</surname><given-names>L.</given-names></name></person-group><article-title>Mucoid <italic toggle="yes">Pseudomonas aeruginosa</italic> is a marker of poor survival in cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>12</volume><year>1992</year><fpage>158</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">1641272</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.1950120306</pub-id></element-citation></ref><ref id="bib41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parad</surname><given-names>R.B.</given-names></name><name name-style="western"><surname>Gerard</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Zurakowski</surname><given-names>D.</given-names></name><name name-style="western"><surname>Nichols</surname><given-names>D.P.</given-names></name><name name-style="western"><surname>Pier</surname><given-names>G.B.</given-names></name></person-group><article-title>Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid <italic toggle="yes">Pseudomonas aeruginosa</italic> infection and immune status and only modestly by genotype</article-title><source>Infect Immun</source><volume>67</volume><year>1999</year><fpage>4744</fpage><lpage>4750</lpage><pub-id pub-id-type="pmid">10456926</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/iai.67.9.4744-4750.1999</pub-id><pub-id pub-id-type="pmcid">PMC96804</pub-id></element-citation></ref><ref id="bib42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demko</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Byard</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>Davis</surname><given-names>P.B.</given-names></name></person-group><article-title>Gender differences in cystic fibrosis: <italic toggle="yes">Pseudomonas aeruginosa</italic> infection</article-title><source>J Clin Epidemiol</source><volume>48</volume><year>1995</year><fpage>1041</fpage><lpage>1049</lpage><pub-id pub-id-type="pmid">7775991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0895-4356(94)00230-n</pub-id></element-citation></ref><ref id="bib43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nixon</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Carzino</surname><given-names>R.</given-names></name><name name-style="western"><surname>Carlin</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Olinsky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>C.F.</given-names></name></person-group><article-title>Clinical outcome after early <italic toggle="yes">Pseudomonas aeruginosa</italic> infection in cystic fibrosis</article-title><source>J Pediatr</source><volume>138</volume><year>2001</year><fpage>699</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">11343046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mpd.2001.112897</pub-id></element-citation></ref><ref id="bib44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pressler</surname><given-names>T.</given-names></name></person-group><article-title>IgG subclasses and chronic bacterial infection. Subclass antibodies and the clinical course of chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> lung infection in cystic fibrosis</article-title><source>APMIS Suppl</source><volume>66</volume><year>1996</year><fpage>1</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">8972694</pub-id></element-citation></ref><ref id="bib45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stutman</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Marks</surname><given-names>M.I.</given-names></name></person-group><article-title>Pulmonary infections in children with cystic fibrosis</article-title><source>Semin Respir Infect</source><volume>2</volume><year>1987</year><fpage>166</fpage><lpage>176</lpage><pub-id pub-id-type="pmid">3317617</pub-id></element-citation></ref><ref id="bib46"><label>46.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Ballestero</surname><given-names>S.</given-names></name><name name-style="western"><surname>Escobar</surname><given-names>H.</given-names></name><name name-style="western"><surname>Villaverde</surname><given-names>R.</given-names></name><name name-style="western"><surname>Negredo</surname><given-names>P.</given-names></name><name name-style="western"><surname>Elia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ojeda- Vargas</surname><given-names>M.</given-names></name></person-group><chapter-title>Microbiological parameters and clinical evolution in cystic fibrosis</chapter-title><person-group person-group-type="editor"><name name-style="western"><surname>Escobar</surname><given-names>H.</given-names></name><name name-style="western"><surname>Baquero</surname><given-names>F.</given-names></name><name name-style="western"><surname>Su&#225;rez</surname><given-names>L.</given-names></name></person-group><source>Clinical ecology of cystic fibrosis</source><year>1993</year><publisher-name>Excerpta Medica</publisher-name><publisher-loc>Amsterdam</publisher-loc><fpage>55</fpage><lpage>62</lpage></element-citation></ref><ref id="bib47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliver</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baquero</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bl&#225;zquez</surname><given-names>J.</given-names></name></person-group><article-title>The mismatch repair system (<italic toggle="yes">mutS</italic>, <italic toggle="yes">mutL</italic> and <italic toggle="yes">uvrD</italic> genes) in <italic toggle="yes">Pseudomonas aeruginosa</italic>: molecular characterization of naturally occurring mutants</article-title><source>Mol Microbiol</source><volume>43</volume><year>2002</year><fpage>1641</fpage><lpage>1650</lpage><pub-id pub-id-type="pmid">11952911</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2958.2002.02855.x</pub-id></element-citation></ref><ref id="bib48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spencer</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Kas</surname><given-names>A.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>E.E.</given-names></name><name name-style="western"><surname>Raymond</surname><given-names>C.K.</given-names></name><name name-style="western"><surname>Sims</surname><given-names>E.H.</given-names></name><name name-style="western"><surname>Hastings</surname><given-names>M.</given-names></name></person-group><article-title>Whole-genome sequence variation among multiple isolates of <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>J Bacterial</source><volume>185</volume><year>2003</year><fpage>1316</fpage><lpage>1325</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JB.185.4.1316-1325.2003</pub-id><pub-id pub-id-type="pmcid">PMC142842</pub-id><pub-id pub-id-type="pmid">12562802</pub-id></element-citation></ref><ref id="bib49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ernst</surname><given-names>R.K.</given-names></name><name name-style="western"><surname>Yi</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lim</surname><given-names>K.B.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Hackett</surname><given-names>M.</given-names></name></person-group><article-title>Specific lipopolysaccharide found in cystic fibrosis airway <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Science</source><volume>286</volume><year>1999</year><fpage>1561</fpage><lpage>1565</lpage><pub-id pub-id-type="pmid">10567263</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.286.5444.1561</pub-id></element-citation></ref><ref id="bib50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Hennigan</surname><given-names>R.F.</given-names></name><name name-style="western"><surname>Hilliard</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Ochsner</surname><given-names>U.A.</given-names></name><name name-style="western"><surname>Parvatiyar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kamani</surname><given-names>M.C.</given-names></name></person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic> anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis</article-title><source>Dev Cell</source><volume>3</volume><year>2002</year><fpage>593</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">12408810</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1534-5807(02)00295-2</pub-id></element-citation></ref><ref id="bib51"><label>51.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Cant&#243;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>A.</given-names></name><name name-style="western"><surname>Baquero</surname><given-names>F.</given-names></name></person-group><chapter-title>Microbiolog&#237;a de las v&#237;as respiratorias en la fibrosis qu&#237;stica</chapter-title><person-group person-group-type="editor"><name name-style="western"><surname>Dapena Fern&#225;ndez</surname><given-names>F.J.</given-names></name></person-group><source>Fibrosis qu&#237;stica, atenci&#243;n integral, manejo cl&#237;nico y puesta al d&#237;a</source><year>1998</year><publisher-name>Editorial Alhulia</publisher-name><publisher-loc>Granada</publisher-loc><fpage>105</fpage><lpage>158</lpage></element-citation></ref><ref id="bib52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henwood</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Livermore</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>James</surname><given-names>D.</given-names></name><name name-style="western"><surname>Warner</surname><given-names>M.</given-names></name><collab>and the <italic toggle="yes">Pseudomonas</italic> Study Group</collab></person-group><article-title>Antimicrobial susceptibility of <italic toggle="yes">Pseudomonas aeruginosa</italic>: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test</article-title><source>J Antimicrob Chemother</source><volume>47</volume><year>2001</year><fpage>789</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">11389111</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/47.6.789</pub-id></element-citation></ref><ref id="bib53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenfeld</surname><given-names>M.</given-names></name><name name-style="western"><surname>Emerson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Accurso</surname><given-names>F.</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>D.</given-names></name><name name-style="western"><surname>Castile</surname><given-names>R.</given-names></name><name name-style="western"><surname>Grimwood</surname><given-names>K.</given-names></name></person-group><article-title>Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>28</volume><year>1999</year><fpage>321</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">10536062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1099-0496(199911)28:5&lt;321::aid-ppul3&gt;3.0.co;2-v</pub-id></element-citation></ref><ref id="bib54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Grimwood</surname><given-names>K.</given-names></name><name name-style="western"><surname>Carlin</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Carzino</surname><given-names>R.</given-names></name><name name-style="western"><surname>Olinsky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Phelan</surname><given-names>P.D.</given-names></name></person-group><article-title>Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>21</volume><year>1996</year><fpage>267</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">8726151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1099-0496(199605)21:5&lt;267::AID-PPUL1&gt;3.0.CO;2-K</pub-id></element-citation></ref><ref id="bib55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suri</surname><given-names>R.</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Wallis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Metcalfe</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shute</surname><given-names>J.K.</given-names></name><name name-style="western"><surname>Bush</surname><given-names>A.</given-names></name></person-group><article-title>Safety and use of sputum induction in children with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>35</volume><year>2003</year><fpage>309</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">12629630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.10226</pub-id></element-citation></ref><ref id="bib56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frederiksen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Changing epidemiology of <italic toggle="yes">Pseudomonas aeruginosa</italic> infection in Danish cystic fibrosis patients (1974-1995)</article-title><source>Pediatr Pulmonol</source><volume>8</volume><year>1999</year><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1099-0496(199909)28:3&lt;159::aid-ppul1&gt;3.0.co;2-1</pub-id><pub-id pub-id-type="pmid">10495331</pub-id></element-citation></ref><ref id="bib57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Fiel</surname><given-names>S.B.</given-names></name><name name-style="western"><surname>Mayer-Hamblett</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>B.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name></person-group><article-title>Susceptibility testing of <italic toggle="yes">Pseudomonas aeruginosa</italic> isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis</article-title><source>Chest</source><volume>123</volume><year>2003</year><fpage>1495</fpage><lpage>1502</lpage><pub-id pub-id-type="pmid">12740266</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.123.5.1495</pub-id></element-citation></ref><ref id="bib58"><label>58.</label><mixed-citation publication-type="other">Cystic Fibrosis Foundation Consensus care conferences concepts in care: microbiology and infectious disease in cystic fibrosis, May 17-18, 1994. En: Cystic Fibrosis Foundation, editor. Clinical practice guidelines; 1997.</mixed-citation></ref><ref id="bib59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>M.B.</given-names></name><name name-style="western"><surname>Gilligan</surname><given-names>P.H.</given-names></name></person-group><article-title>Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis</article-title><source>J Clin Microbiol</source><volume>41</volume><year>2003</year><fpage>4009</fpage><lpage>4015</lpage><pub-id pub-id-type="pmid">12958218</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JCM.41.9.4009-4015.2003</pub-id><pub-id pub-id-type="pmcid">PMC193835</pub-id></element-citation></ref><ref id="bib60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>T.W.</given-names></name><name name-style="western"><surname>Brownlee</surname><given-names>K.G.</given-names></name><name name-style="western"><surname>Denton</surname><given-names>M.</given-names></name><name name-style="western"><surname>Littlewood</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Conway</surname><given-names>S.P.</given-names></name></person-group><article-title>Reduction in prevalence of chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> infection at a regional pediatric cystic fibrosis center</article-title><source>Pediatr Pulmonol</source><volume>37</volume><year>2004</year><fpage>104</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">14730654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.10401</pub-id></element-citation></ref><ref id="bib61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nair</surname><given-names>B.</given-names></name><name name-style="western"><surname>Stapp</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stapp</surname><given-names>L.</given-names></name><name name-style="western"><surname>Bugni</surname><given-names>L.</given-names></name><name name-style="western"><surname>Van Dalfsen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name></person-group><article-title>Utility of gram staining for evaluation of the quality of cystic fibrosis sputum samples</article-title><source>J Clin Microbiol</source><volume>40</volume><year>2002</year><fpage>2791</fpage><lpage>2794</lpage><pub-id pub-id-type="pmid">12149331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JCM.40.8.2791-2794.2002</pub-id><pub-id pub-id-type="pmcid">PMC120690</pub-id></element-citation></ref><ref id="bib62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilligan</surname><given-names>P.H.</given-names></name></person-group><article-title>Microbiology of airway disease in patients with cystic fibrosis</article-title><source>Clin Microbiol Rev</source><volume>4</volume><year>1991</year><fpage>35</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">1900735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/cmr.4.1.35</pub-id><pub-id pub-id-type="pmcid">PMC358177</pub-id></element-citation></ref><ref id="bib63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morlin</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Hedges</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name></person-group><article-title>Accuracy and cost of antibiotic susceptibility testing of mixed morphotypes of <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>J Clin Microbiol</source><volume>32</volume><year>1994</year><fpage>1027</fpage><lpage>1030</lpage><pub-id pub-id-type="pmid">8027305</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.32.4.1027-1030.1994</pub-id><pub-id pub-id-type="pmcid">PMC267174</pub-id></element-citation></ref><ref id="bib64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Whittier</surname><given-names>S.</given-names></name><name name-style="western"><surname>Larone</surname><given-names>D.</given-names></name><name name-style="western"><surname>Krzewinski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name></person-group><article-title>Comparison of agar diffusion methodologies for antimicrobial susceptibility testing of <italic toggle="yes">Pseudomonas aeruginosa</italic> isolates from cystic fibrosis patients</article-title><source>J Clin Microbiol</source><volume>38</volume><year>2000</year><fpage>1818</fpage><lpage>1822</lpage><pub-id pub-id-type="pmid">10790106</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.38.5.1818-1822.2000</pub-id><pub-id pub-id-type="pmcid">PMC86597</pub-id></element-citation></ref><ref id="bib65"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haussler</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ziesing</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rademacher</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hoy</surname><given-names>L.</given-names></name><name name-style="western"><surname>Weissbrodt</surname><given-names>H.</given-names></name></person-group><article-title>Evaluation of the Merlin, Micronaut system for automated antimicrobial susceptibility testing of <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Burkholderia</italic> species isolated from cystic fibrosis patients</article-title><source>Eur J Clin Microbiol Infect Dis</source><volume>22</volume><year>2003</year><fpage>496</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">12898284</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10096-003-0974-7</pub-id></element-citation></ref><ref id="bib66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Whittier</surname><given-names>S.</given-names></name><name name-style="western"><surname>Krzewinski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>R.N.</given-names></name></person-group><article-title>Evaluation of reference dilution test methods for antimicrobial susceptibility testing of <italic toggle="yes">Pseudomonas aeruginosa</italic> strains isolated from patients with cystic fibrosis</article-title><source>J Clin Microbiol</source><volume>37</volume><year>1999</year><fpage>2987</fpage><lpage>2991</lpage><pub-id pub-id-type="pmid">10449487</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.37.9.2987-2991.1999</pub-id><pub-id pub-id-type="pmcid">PMC85429</pub-id></element-citation></ref><ref id="bib67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marley</surname><given-names>E.F.</given-names></name><name name-style="western"><surname>Mohla</surname><given-names>C.</given-names></name><name name-style="western"><surname>Campos</surname><given-names>J.M.</given-names></name></person-group><article-title>Evaluation of E-Test for determination of antimicrobial MICs for <italic toggle="yes">Pseudomonas aeruginosa</italic> isolates from cystic fibrosis patients</article-title><source>J Clin Microbiol</source><volume>33</volume><year>1995</year><fpage>3191</fpage><lpage>3193</lpage><pub-id pub-id-type="pmid">8586700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/jcm.33.12.3191-3193.1995</pub-id><pub-id pub-id-type="pmcid">PMC228671</pub-id></element-citation></ref><ref id="bib68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliver</surname><given-names>A.</given-names></name><name name-style="western"><surname>Levin</surname><given-names>B.R.</given-names></name><name name-style="western"><surname>Juan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Baquero</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bl&#225;zquez</surname><given-names>J.</given-names></name></person-group><article-title>Hypermutation and the pre-existence of antibiotic resistance in <italic toggle="yes">Pseudomonas aeruginosa</italic>: implications for susceptibility testing and treatment of chronic infections</article-title><source>Antimicrob Agents Chemother</source><volume>48</volume><year>2004</year><fpage>4226</fpage><lpage>4233</lpage><pub-id pub-id-type="pmid">15504845</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.48.11.4226-4233.2004</pub-id><pub-id pub-id-type="pmcid">PMC525420</pub-id></element-citation></ref><ref id="bib69"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macia</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Borrell</surname><given-names>N.</given-names></name><name name-style="western"><surname>P&#233;rez</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>A.</given-names></name></person-group><article-title>Detection and susceptibility testing of hypermutable <italic toggle="yes">Pseudomonas aeruginosa</italic> strains with the E-test and disk diffusion</article-title><source>Antimicrob Agents Chemother</source><volume>48</volume><year>2004</year><fpage>2665</fpage><lpage>2672</lpage><pub-id pub-id-type="pmid">15215124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.48.7.2665-2672.2004</pub-id><pub-id pub-id-type="pmcid">PMC434203</pub-id></element-citation></ref><ref id="bib70"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chernish</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Aaron</surname><given-names>S.D.</given-names></name></person-group><article-title>Approach to resistant gram-negative bacterial pulmonary infections in patients with cystic fibrosis</article-title><source>Curr Opin Pulm Med</source><volume>9</volume><year>2003</year><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">14534404</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00063198-200311000-00011</pub-id></element-citation></ref><ref id="bib71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moskowitz</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Foster</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Emerson</surname><given-names>J.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name></person-group><article-title>Clinically feasible biofilm susceptibility assay for isolates of <italic toggle="yes">Pseudomonas aeruginosa</italic> from patients with cystic fibrosis</article-title><source>J Clin Microbiol</source><volume>42</volume><year>2004</year><fpage>1915</fpage><lpage>1922</lpage><pub-id pub-id-type="pmid">15131149</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JCM.42.5.1915-1922.2004</pub-id><pub-id pub-id-type="pmcid">PMC404629</pub-id></element-citation></ref><ref id="bib72"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aaron</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Ferris</surname><given-names>W.</given-names></name><name name-style="western"><surname>Ramotar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Vandemheen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Chan</surname><given-names>F.</given-names></name><name name-style="western"><surname>Saginur</surname><given-names>R.</given-names></name></person-group><article-title>Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown <italic toggle="yes">Pseudomonas aeruginosa</italic> isolates cultured from sputa of adults with cystic fibrosis</article-title><source>J Clin Microbiol</source><volume>40</volume><year>2002</year><fpage>4172</fpage><lpage>4179</lpage><pub-id pub-id-type="pmid">12409393</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/JCM.40.11.4172-4179.2002</pub-id><pub-id pub-id-type="pmcid">PMC139693</pub-id></element-citation></ref><ref id="bib73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Worlitzsch</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tarran</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ulrich</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schwab</surname><given-names>U.</given-names></name><name name-style="western"><surname>Cekici</surname><given-names>A.</given-names></name><name name-style="western"><surname>Meyer</surname><given-names>K.C.</given-names></name></person-group><article-title>Effects of reduced mucus oxygen concentration in airway <italic toggle="yes">Pseudomonas</italic> infections of cystic fibrosis patients</article-title><source>J Clin Invest</source><volume>109</volume><year>2002</year><fpage>317</fpage><lpage>325</lpage><pub-id pub-id-type="pmid">11827991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI13870</pub-id><pub-id pub-id-type="pmcid">PMC150856</pub-id></element-citation></ref><ref id="bib74"><label>74.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Osterholm</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Hedberg</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>K.A.</given-names></name></person-group><chapter-title>Epidemiologic principles</chapter-title><edition>5th ed.</edition><person-group person-group-type="editor"><name name-style="western"><surname>Dolin</surname><given-names>R.</given-names></name></person-group><series>Mandel, Douglas and Bennett's principles and practice of infectious diseases</series><volume>Vol 1</volume><year>2000</year><publisher-name>Churchill Livingstone</publisher-name><publisher-loc>Philadelphia</publisher-loc><fpage>156</fpage><lpage>167</lpage></element-citation></ref><ref id="bib75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deretic</surname><given-names>V.</given-names></name><name name-style="western"><surname>Schurr</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>H.</given-names></name></person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic>, mucoid and the chronic infection phenotype in cystic fibrosis</article-title><source>Trends Microbiol</source><volume>3</volume><year>1995</year><fpage>351</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">8520888</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0966-842x(00)88974-x</pub-id></element-citation></ref><ref id="bib76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pedersen</surname><given-names>S.S.</given-names></name></person-group><article-title>Lung infection with alginate-producing mucoid <italic toggle="yes">Pseudomonas aeruginosa</italic> in cystic fibrosis</article-title><source>APMIS Suppl</source><volume>28</volume><year>1992</year><fpage>1</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">1449848</pub-id></element-citation></ref><ref id="bib77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hutchison</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Govan</surname><given-names>J.R.</given-names></name></person-group><article-title>Pathogenecity of microbes associated with cystic fibrosis</article-title><source>Microbes Infect</source><volume>1</volume><year>1999</year><fpage>1005</fpage><lpage>1014</lpage><pub-id pub-id-type="pmid">10617932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1286-4579(99)80518-8</pub-id></element-citation></ref><ref id="bib78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Whittier</surname><given-names>S.</given-names></name><name name-style="western"><surname>Krzewinski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Larone</surname><given-names>D.</given-names></name></person-group><article-title>Comparison of two commercial systems (Vitek and MicroScan- WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients</article-title><source>Diagn Microbiol Infect Dis</source><volume>39</volume><year>2001</year><fpage>257</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">11404070</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0732-8893(01)00234-6</pub-id></element-citation></ref><ref id="bib79"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aaron</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Ramotar</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ferris</surname><given-names>W.</given-names></name><name name-style="western"><surname>Vandemheen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Saginur</surname><given-names>R.</given-names></name><name name-style="western"><surname>Tullis</surname><given-names>E.</given-names></name></person-group><article-title>Adult cystic fibrosis exacerbations and new strains of <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Am J Respir Crit Care Med</source><volume>69</volume><year>2004</year><fpage>811</fpage><lpage>815</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200309-1306OC</pub-id><pub-id pub-id-type="pmid">14670805</pub-id></element-citation></ref><ref id="bib80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denton</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wilcox</surname><given-names>M.H.</given-names></name></person-group><article-title>Antimicrobial treatment of pulmonary colonization and infection by <italic toggle="yes">Pseudomonas aeruginosa</italic> in cystic fibrosis patients</article-title><source>J Antimicrob Chemother</source><volume>40</volume><year>1997</year><fpage>468</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">9372414</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/40.4.468</pub-id></element-citation></ref><ref id="bib81"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramsey</surname><given-names>B.W.</given-names></name></person-group><article-title>Management of pulmonary disease in patients with cystic fibrosis</article-title><source>N Engl J Med</source><volume>335</volume><year>1996</year><fpage>179</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">8657217</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199607183350307</pub-id></element-citation></ref><ref id="bib82"><label>82.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Cobos</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gartner</surname><given-names>S.</given-names></name><name name-style="western"><surname>Li&#241;&#225;n</surname><given-names>S.</given-names></name></person-group><chapter-title>Fibrosis qu&#237;stica</chapter-title><person-group person-group-type="editor"><name name-style="western"><surname>Caminero Luna</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Fernandez Fau</surname><given-names>L.</given-names></name></person-group><source>Manual de neumolog&#237;a y cirug&#237;a tor&#225;cica</source><year>1998</year><publisher-name>Editores M&#233;dicos</publisher-name><publisher-loc>Madrid</publisher-loc><fpage>1217</fpage><lpage>1236</lpage></element-citation></ref><ref id="bib83"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doring</surname><given-names>G.</given-names></name><name name-style="western"><surname>Conway</surname><given-names>S.P.</given-names></name><name name-style="western"><surname>Heijerman</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Hodson</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>A.</given-names></name></person-group><article-title>Antibiotic therapy against <italic toggle="yes">Pseudomonas aeruginosa</italic> in cystic fibrosis: a European consensus</article-title><source>Eur Respir J</source><volume>16</volume><year>2000</year><fpage>749</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">11106223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1034/j.1399-3003.2000.16d30.x</pub-id></element-citation></ref><ref id="bib84"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walters</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Roe</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bugnicourt</surname><given-names>A.</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>P.S.</given-names></name></person-group><article-title>Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of <italic toggle="yes">Pseudomonas aeruginosa</italic> biofilms to ciprofloxacin and tobramycin</article-title><source>Antimicrob Agents Chemother</source><volume>47</volume><year>2003</year><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">12499208</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.47.1.317-323.2003</pub-id><pub-id pub-id-type="pmcid">PMC148957</pub-id></element-citation></ref><ref id="bib85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodson</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Gallagher</surname><given-names>C.G.</given-names></name><name name-style="western"><surname>Govan</surname><given-names>J.R.</given-names></name></person-group><article-title>A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis</article-title><source>Eur Respir J</source><volume>20</volume><year>2002</year><fpage>658</fpage><lpage>664</lpage><pub-id pub-id-type="pmid">12358344</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.02.00248102</pub-id></element-citation></ref><ref id="bib86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mukhopadhyay</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cater</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Ogston</surname><given-names>S.</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Olver</surname><given-names>R.E.</given-names></name></person-group><article-title>Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks</article-title><source>Thorax</source><volume>51</volume><year>1996</year><fpage>364</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">8733486</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.51.4.364</pub-id><pub-id pub-id-type="pmcid">PMC1090669</pub-id></element-citation></ref><ref id="bib87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Den Hollander</surname><given-names>J.G.</given-names></name><name name-style="western"><surname>Horrevorts</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Van Goor</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Verbrugh</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Mouton</surname><given-names>J.W.</given-names></name></person-group><article-title>Synergism between tobramycin and ceftazidime against a resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> strain, tested in an in vitro pharmacokinetic model</article-title><source>Antimicrob Agents Chemother</source><volume>41</volume><year>1997</year><fpage>95</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">8980762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.41.1.95</pub-id><pub-id pub-id-type="pmcid">PMC163667</pub-id></element-citation></ref><ref id="bib88"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mueller</surname><given-names>M.</given-names></name><name name-style="western"><surname>De la Pena</surname><given-names>A.</given-names></name><name name-style="western"><surname>Derendorf</surname><given-names>H.</given-names></name></person-group><article-title>Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MIC</article-title><source>Antimicrob Agents Chemother</source><volume>48</volume><year>2004</year><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">14742182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.48.2.369-377.2004</pub-id><pub-id pub-id-type="pmcid">PMC321563</pub-id></element-citation></ref><ref id="bib89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>J.T.</given-names></name></person-group><article-title>The mode of action of 4-quinolones and possible mechanisms of resistance</article-title><source>J Antimicrob Chemother</source><volume>18</volume><issue>Suppl D</issue><year>1986</year><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">3542946</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/18.supplement_d.21</pub-id></element-citation></ref><ref id="bib90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phillips Phillips</surname><given-names>I.</given-names></name><name name-style="western"><surname>Culebras</surname><given-names>E.</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>F.</given-names></name><name name-style="western"><surname>Baquero</surname><given-names>F.</given-names></name></person-group><article-title>Induction of the SOS response by new 4-quinolones</article-title><source>J Antimicrob Chemother</source><volume>20</volume><year>1987</year><fpage>631</fpage><lpage>638</lpage><pub-id pub-id-type="pmid">3323160</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/20.5.631</pub-id></element-citation></ref><ref id="bib91"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gunderson</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Hovde</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Fromm</surname><given-names>T.L.</given-names></name><name name-style="western"><surname>Reed</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Rotschafer</surname><given-names>J.C.</given-names></name></person-group><article-title>Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> in an in vitro pharmacodynamic model</article-title><source>Antimicrob Agents Chemother</source><volume>47</volume><year>2003</year><fpage>905</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">12604520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.47.3.905-909.2003</pub-id><pub-id pub-id-type="pmcid">PMC149291</pub-id></element-citation></ref><ref id="bib92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moller</surname><given-names>N.E.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Antibiotic treatment of chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> infection in cystic fibrosis patients</article-title><source>Scand J Infect Dis Suppl</source><volume>29</volume><year>1981</year><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">6458884</pub-id></element-citation></ref><ref id="bib93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szaff</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Antibiotic treatment of <italic toggle="yes">Staphylococcus aureus</italic> infection in cystic fibrosis</article-title><source>Acta Paediatr Scand</source><volume>71</volume><year>1982</year><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1651-2227.1982.tb09526.x</pub-id><pub-id pub-id-type="pmid">7180452</pub-id></element-citation></ref><ref id="bib94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parekh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Subbarao</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sweezey</surname><given-names>N.</given-names></name><name name-style="western"><surname>Matlow</surname><given-names>A.</given-names></name><name name-style="western"><surname>Corey</surname><given-names>M.</given-names></name></person-group><article-title>Association between prophylactic antibiotic usage and and early onset of <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Pediatr Pulmonol</source><volume>17</volume><issue>Suppl</issue><year>1998</year><fpage>426A</fpage></element-citation></ref><ref id="bib95"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ratjen</surname><given-names>F.</given-names></name><name name-style="western"><surname>Doring</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nikolaizik</surname><given-names>W.H.</given-names></name></person-group><article-title>Effect of inhaled tobramycin on early <italic toggle="yes">Pseudomonas aeruginosa</italic> colonisation in patients with cystic fibrosis</article-title><source>Lancet</source><volume>358</volume><year>2001</year><fpage>983</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">11583754</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(01)06124-4</pub-id></element-citation></ref><ref id="bib96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frederiksen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Delay of recurrence of <italic toggle="yes">Pseudomonas aeruginosa</italic> in patients with cystic fibrosis with inhaled colistin and oral ciproxin: a comparison between 3 weeks and 3 months of treatment</article-title><source>Pediatr Pulmonol</source><issue>Suppl 14</issue><year>1997</year><fpage>298 A</fpage></element-citation></ref><ref id="bib97"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodson</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Butland</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Batten</surname><given-names>J.C.</given-names></name></person-group><article-title>Oral ciprofloxacin compared with conventional intravenous treatment for <italic toggle="yes">Pseudomonas aeruginosa</italic> infection in adults with cystic fibrosis</article-title><source>Lancet</source><volume>1</volume><year>1987</year><fpage>235</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">2880066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(87)90062-6</pub-id></element-citation></ref><ref id="bib98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shalit</surname><given-names>I.</given-names></name><name name-style="western"><surname>Stutman</surname><given-names>H.R.</given-names></name><name name-style="western"><surname>Marks</surname><given-names>M.I.</given-names></name><name name-style="western"><surname>Chartrand</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Hilman</surname><given-names>B.C.</given-names></name></person-group><article-title>Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis</article-title><source>Am J Med</source><volume>82</volume><year>1987</year><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">3555035</pub-id></element-citation></ref><ref id="bib99"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Church</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Kanga</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Kuhn</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Rubio</surname><given-names>T.T.</given-names></name><name name-style="western"><surname>Spohn</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>J.C.</given-names></name></person-group><article-title>Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study <italic toggle="yes">vs</italic>. Ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group</article-title><source>Pediatr Infect Dis J</source><volume>16</volume><year>1997</year><fpage>97</fpage><lpage>105</lpage><pub-id pub-id-type="pmid">9002118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00006454-199701000-00031</pub-id></element-citation></ref><ref id="bib100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Littlewood</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>M.G.</given-names></name><name name-style="western"><surname>Ghoneim</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Ramsden</surname><given-names>C.H.</given-names></name></person-group><article-title>Nebulised colomycin for early <italic toggle="yes">Pseudomonas</italic> colonisation in cystic fibrosis</article-title><source>Lancet</source><volume>1</volume><year>1985</year><fpage>865</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(85)92222-6</pub-id><pub-id pub-id-type="pmid">2858720</pub-id></element-citation></ref><ref id="bib101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiesemann</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Steinkamp</surname><given-names>G.</given-names></name><name name-style="western"><surname>Ratjen</surname><given-names>F.</given-names></name><name name-style="western"><surname>Przyklenk</surname><given-names>B.</given-names></name><name name-style="western"><surname>D&#246;ring</surname><given-names>G.</given-names></name><name name-style="western"><surname>Von der Hardt</surname><given-names>H.</given-names></name></person-group><article-title>Placebo-controlled, double-blind, randomized study for early treatment of <italic toggle="yes">Pseudomonas aeruginosa</italic> colonization in patients with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>25</volume><year>1998</year><fpage>88</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">9516091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1099-0496(199802)25:2&lt;88::aid-ppul3&gt;3.0.co;2-j</pub-id></element-citation></ref><ref id="bib102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valerius</surname><given-names>N.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Prevention of chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> colonisation in cystic fibrosis by early treatment</article-title><source>Lancet</source><volume>338</volume><year>1991</year><fpage>725</fpage><lpage>726</lpage><pub-id pub-id-type="pmid">1679870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0140-6736(91)91446-2</pub-id></element-citation></ref><ref id="bib103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramsey</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Pepe</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Quan</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Montgomery</surname><given-names>A.B.</given-names></name><name name-style="western"><surname>Williams-Warren</surname><given-names>J.</given-names></name></person-group><article-title>Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group</article-title><source>N Engl J Med</source><volume>340</volume><year>1999</year><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">9878641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199901073400104</pub-id></element-citation></ref><ref id="bib104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis</article-title><source>Paediatr Drugs</source><volume>2</volume><year>2000</year><fpage>451</fpage><lpage>463</lpage><pub-id pub-id-type="pmid">11127845</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00128072-200002060-00004</pub-id></element-citation></ref><ref id="bib105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nir</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lanng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Johansen</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name></person-group><article-title>Long-term survival and nutritional data in patients with cystic fibrosis treated in a Danish centre</article-title><source>Thorax</source><volume>51</volume><year>1996</year><fpage>1023</fpage><lpage>1027</lpage><pub-id pub-id-type="pmid">8977604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.51.10.1023</pub-id><pub-id pub-id-type="pmcid">PMC472653</pub-id></element-citation></ref><ref id="bib106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinkamp</surname><given-names>G.</given-names></name><name name-style="western"><surname>Tummler</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gappa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Albus</surname><given-names>A.</given-names></name><name name-style="western"><surname>Potel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Doring</surname><given-names>G.</given-names></name></person-group><article-title>Long-term tobramycin aerosol therapy in cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>6</volume><year>1989</year><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">2494640</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.1950060207</pub-id></element-citation></ref><ref id="bib107"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jensen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Garne</surname><given-names>S.</given-names></name><name name-style="western"><surname>Heilmann</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name></person-group><article-title>Colistin inhalation therapy in cystic fibrosis patients with chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> lung infection</article-title><source>J Antimicrob Chemother</source><volume>19</volume><year>1987</year><fpage>831</fpage><lpage>838</lpage><pub-id pub-id-type="pmid">3301785</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/19.6.831</pub-id></element-citation></ref><ref id="bib108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramsey</surname><given-names>B.W.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A.L.</given-names></name></person-group><article-title>Safety and efficacy of tobramycin solution for inhalation in patients with cystic fibrosis. The results of 2 phases placebo controlled trials</article-title><source>Pediatr Pulmonol</source><volume>14</volume><year>1997</year><fpage>137</fpage><lpage>138</lpage></element-citation></ref><ref id="bib109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>D.</given-names></name><name name-style="western"><surname>Stableforth</surname><given-names>D.</given-names></name></person-group><article-title>The treatment of respiratory <italic toggle="yes">Pseudomonas</italic> infection in cystic fibrosis: what drug and which way?</article-title><source>Drugs</source><volume>60</volume><year>2000</year><fpage>1053</fpage><lpage>1064</lpage><pub-id pub-id-type="pmid">11129122</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-200060050-00006</pub-id></element-citation></ref><ref id="bib110"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Doershuk</surname><given-names>C.</given-names></name><name name-style="western"><surname>Goldmann</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gore</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hilman</surname><given-names>B.</given-names></name><name name-style="western"><surname>Marks</surname><given-names>M.</given-names></name></person-group><article-title>Comparison of a &#946;-lactam alone versus &#946;-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibtrosis</article-title><source>J Pediatr</source><volume>134</volume><year>1999</year><fpage>413</fpage><lpage>421</lpage><pub-id pub-id-type="pmid">10190914</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-3476(99)70197-6</pub-id></element-citation></ref><ref id="bib111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Gracia</surname><given-names>J.</given-names></name><name name-style="western"><surname>M&#225;iz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Prados</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vendrell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Baranda</surname><given-names>F.</given-names></name><name name-style="western"><surname>Escribano</surname><given-names>A.</given-names></name></person-group><article-title>Conferencia de Consenso: Antibi&#243;ticos nebulizados en pacientes con fibrosis qu&#237;stica</article-title><source>Med Clin (Barc)</source><volume>117</volume><year>2001</year><fpage>233</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">11481100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0025-7753(01)72070-2</pub-id></element-citation></ref><ref id="bib112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dapena</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ramos</surname><given-names>M.</given-names></name><name name-style="western"><surname>G&#243;mez</surname><given-names>I.</given-names></name></person-group><article-title>Actualizaci&#243;n terap&#233;utica en fibrosis qu&#237;stica</article-title><source>Inf Ter Sist Nac Salud</source><volume>27</volume><year>2003</year><fpage>129</fpage><lpage>144</lpage></element-citation></ref><ref id="bib113"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Touw</surname><given-names>D.J.</given-names></name></person-group><article-title>Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis</article-title><source>Pharm World Sci</source><volume>20</volume><year>1998</year><fpage>149</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">9762727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1023/a:1008634911114</pub-id></element-citation></ref><ref id="bib114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rey</surname><given-names>E.</given-names></name><name name-style="western"><surname>Treluyer</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Pons</surname><given-names>G.</given-names></name></person-group><article-title>Drug disposition in cystic fibrosis</article-title><source>Clin Pharmacokinet</source><volume>35</volume><year>1998</year><fpage>313</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">9812180</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-199835040-00004</pub-id></element-citation></ref><ref id="bib115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Touw</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Vinks</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Mouton</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Horrevorts</surname><given-names>A.M.</given-names></name></person-group><article-title>Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions</article-title><source>Clin Pharmacokinet</source><volume>35</volume><year>1998</year><fpage>437</fpage><lpage>459</lpage><pub-id pub-id-type="pmid">9884816</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-199835060-00003</pub-id></element-citation></ref><ref id="bib116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.P.</given-names></name><name name-style="western"><surname>Unadkat</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Al-Habet</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>O'Sullivan</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Williams- Warren</surname><given-names>J.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A.L.</given-names></name></person-group><article-title>Disposition of drugs in cystic fibrosis. IV. Mechanisms for enhanced renal clearance of ticarcillin</article-title><source>Clin Pharmacol Ther</source><volume>54</volume><year>1993</year><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">8375124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/clpt.1993.150</pub-id></element-citation></ref><ref id="bib117"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reed</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Aronoff</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Stern</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Yamashita</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Myers</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Friedhoff</surname><given-names>L.T.</given-names></name></person-group><article-title>Single-dose pharmacokinetics of aztreonam in children with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>2</volume><year>1986</year><fpage>282</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">3774385</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.1950020506</pub-id></element-citation></ref><ref id="bib118"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hedman</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alvan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Strandvik</surname><given-names>B.</given-names></name><name name-style="western"><surname>Arvidsson</surname><given-names>A.</given-names></name></person-group><article-title>Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis</article-title><source>Clin Pharmacokinet</source><volume>18</volume><year>1990</year><fpage>168</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">2180614</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-199018020-00006</pub-id></element-citation></ref><ref id="bib119"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bins</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Mattie</surname><given-names>H.</given-names></name></person-group><article-title>The tubular excretion of benzylpenicillin in patients with cystic fibrosis</article-title><source>Br J Clin Pharmacol</source><volume>27</volume><year>1989</year><fpage>2 91</fpage><lpage>294</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2125.1989.tb05367.x</pub-id><pub-id pub-id-type="pmcid">PMC1379825</pub-id><pub-id pub-id-type="pmid">2719893</pub-id></element-citation></ref><ref id="bib120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vance-Bryan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Guay</surname><given-names>D.R.P.</given-names></name><name name-style="western"><surname>Rotschafer</surname><given-names>J.C.</given-names></name></person-group><article-title>Clinical pharmacokinetics of ciprofloxacin</article-title><source>Clin Pharmacokinet</source><volume>19</volume><year>1990</year><fpage>434</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">2292168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-199019060-00003</pub-id></element-citation></ref><ref id="bib121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Todd</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Benfield</surname><given-names>P.</given-names></name></person-group><article-title>Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use</article-title><source>Drugs</source><volume>39</volume><year>1990</year><fpage>264</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">2184003</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-199039020-00008</pub-id></element-citation></ref><ref id="bib122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perry</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Brogden</surname><given-names>R.N.</given-names></name></person-group><article-title>Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy</article-title><source>Drugs</source><volume>52</volume><year>1996</year><fpage>125</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">8799689</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-199652010-00009</pub-id></element-citation></ref><ref id="bib123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Friedel</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>McTavish</surname><given-names>D.</given-names></name></person-group><article-title>Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy</article-title><source>Drugs</source><volume>44</volume><year>1992</year><fpage>750</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">1280567</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-199244050-00007</pub-id></element-citation></ref><ref id="bib124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rains</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>Bryson</surname><given-names>H.M.</given-names></name><name name-style="western"><surname>Peters</surname><given-names>D.H.</given-names></name></person-group><article-title>Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy</article-title><source>Drugs</source><volume>49</volume><year>1995</year><fpage>577</fpage><lpage>617</lpage><pub-id pub-id-type="pmid">7789291</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-199549040-00008</pub-id></element-citation></ref><ref id="bib125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barradell</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Bryson</surname><given-names>H.M.</given-names></name></person-group><article-title>Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use</article-title><source>Drugs</source><volume>47</volume><year>1994</year><fpage>471</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">7514976</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-199447030-00007</pub-id></element-citation></ref><ref id="bib126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perry</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Markham</surname><given-names>A.</given-names></name></person-group><article-title>Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections</article-title><source>Drugs</source><volume>57</volume><year>1999</year><fpage>805</fpage><lpage>843</lpage><pub-id pub-id-type="pmid">10353303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-199957050-00017</pub-id></element-citation></ref><ref id="bib127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buckley</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Brogden</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Barradell</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Goa</surname><given-names>K.L.</given-names></name></person-group><article-title>Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy</article-title><source>Drugs</source><volume>44</volume><year>1992</year><fpage>408</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">1382937</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-199244030-00008</pub-id></element-citation></ref><ref id="bib128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiseman</surname><given-names>L.R.</given-names></name><name name-style="western"><surname>Wagstaff</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Brogden</surname><given-names>R.N.</given-names></name><name name-style="western"><surname>Bryson</surname><given-names>H.M.</given-names></name></person-group><article-title>Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy</article-title><source>Drugs</source><volume>50</volume><year>1995</year><fpage>73</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">7588092</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-199550010-00007</pub-id></element-citation></ref><ref id="bib129"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Ballow</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Booker</surname><given-names>B.M.</given-names></name><name name-style="western"><surname>Forrest</surname><given-names>A.</given-names></name><name name-style="western"><surname>Schentag</surname><given-names>J.J.</given-names></name></person-group><article-title>Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients</article-title><source>Clin Ther</source><volume>23</volume><year>2001</year><fpage>1231</fpage><lpage>1244</lpage><pub-id pub-id-type="pmid">11558860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0149-2918(01)80103-x</pub-id></element-citation></ref><ref id="bib130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aminimanizani</surname><given-names>A.</given-names></name><name name-style="western"><surname>Beringer</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tsang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Jelliffe</surname><given-names>R.W.</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>B.J.</given-names></name></person-group><article-title>Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis</article-title><source>J Antimicrob Chemother</source><volume>50</volume><year>2002</year><fpage>553</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">12356801</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/dkf168</pub-id></element-citation></ref><ref id="bib131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canis</surname><given-names>F.</given-names></name><name name-style="western"><surname>Husson</surname><given-names>M.O.</given-names></name><name name-style="western"><surname>Turck</surname><given-names>D.</given-names></name><name name-style="western"><surname>Vic</surname><given-names>P.</given-names></name><name name-style="western"><surname>Launay</surname><given-names>V.</given-names></name><name name-style="western"><surname>Ategbo</surname><given-names>S.</given-names></name></person-group><article-title>Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients</article-title><source>J Antimicrob Chemother</source><volume>39</volume><year>1997</year><fpage>431</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">9096197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/39.3.431</pub-id></element-citation></ref><ref id="bib132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boeckh</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lode</surname><given-names>H.</given-names></name><name name-style="western"><surname>Borner</surname><given-names>K.</given-names></name><name name-style="western"><surname>H&#246;ffken</surname><given-names>G.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>J.</given-names></name><name name-style="western"><surname>Koeppe</surname><given-names>P.</given-names></name></person-group><article-title>Pharmacokinetics and serum bactericidal activity of vancomycin alone and in combination with ceftazidime in healthy volunteers</article-title><source>Antimicrob Agents Chemother</source><volume>32</volume><year>1988</year><fpage>92</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">3279907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.32.1.92</pub-id><pub-id pub-id-type="pmcid">PMC172105</pub-id></element-citation></ref><ref id="bib133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verbist</surname><given-names>L.</given-names></name><name name-style="western"><surname>Tjandramaga</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hendrickx</surname><given-names>B.</given-names></name><name name-style="western"><surname>Van Hecken</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Van Melle</surname><given-names>P.</given-names></name><name name-style="western"><surname>Verbesselt</surname><given-names>R.</given-names></name></person-group><article-title>In vitro activity and human pharmacokinetics of teicoplanin</article-title><source>Antimicrob Agents Chemother</source><volume>26</volume><year>1984</year><fpage>881</fpage><lpage>886</lpage><pub-id pub-id-type="pmid">6240962</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.26.6.881</pub-id><pub-id pub-id-type="pmcid">PMC180043</pub-id></element-citation></ref><ref id="bib134"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geller</surname><given-names>D.E.</given-names></name><name name-style="western"><surname>Pitlick</surname><given-names>W.H.</given-names></name><name name-style="western"><surname>Nardella</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Tracewell</surname><given-names>W.G.</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>B.W.</given-names></name></person-group><article-title>Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis</article-title><source>Chest</source><volume>122</volume><year>2002</year><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">12114362</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.122.1.219</pub-id></element-citation></ref><ref id="bib135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klastersky</surname><given-names>J.</given-names></name><name name-style="western"><surname>Daneu</surname><given-names>D.</given-names></name><name name-style="western"><surname>Swings</surname><given-names>G.</given-names></name><name name-style="western"><surname>Weerts</surname><given-names>D.</given-names></name></person-group><article-title>Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections</article-title><source>J Infect Dis</source><volume>129</volume><year>1974</year><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">4810941</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/129.2.187</pub-id></element-citation></ref><ref id="bib136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>E.T.</given-names></name><name name-style="western"><surname>Young</surname><given-names>L.S.</given-names></name><name name-style="western"><surname>Hewitt</surname><given-names>W.L.</given-names></name></person-group><article-title>Simultaneous antibiotic levels in &#8220;breakthrough&#8221; gram-negative rod bacteremia</article-title><source>Am J Med</source><volume>61</volume><year>1976</year><fpage>493</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">788512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0002-9343(76)90328-4</pub-id></element-citation></ref><ref id="bib137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drusano</surname><given-names>G.L.</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Standiford</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Moody</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Schimpff</surname><given-names>S.C.</given-names></name></person-group><article-title>Integration of selected pharmacologic and microbiologic properties of three new &#946;-lactam antibiotics: a hypothesis for rational comparison</article-title><source>Rev Infect Dis</source><volume>6</volume><year>1984</year><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">6330835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/clinids/6.3.357</pub-id></element-citation></ref><ref id="bib138"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinstein</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Stratton</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Hawley</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Ackley</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hawley</surname><given-names>H.B.</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>P.A.</given-names></name></person-group><article-title>Multicenter collaborative evaluation of a standarized serum bactericidal test as a prognostic indicator in infective endocarditis</article-title><source>Am J Med</source><volume>78</volume><year>1985</year><fpage>262</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">3881943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0002-9343(85)90436-x</pub-id></element-citation></ref><ref id="bib139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmood</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bailan</surname><given-names>J.D.</given-names></name></person-group><article-title>The pharmacokinetic principles behind scaling from preclinical results to phase I protocols</article-title><source>Clin Pharmacokinet</source><volume>36</volume><year>1999</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-199936010-00001</pub-id><pub-id pub-id-type="pmid">9989339</pub-id></element-citation></ref><ref id="bib140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schentag</surname><given-names>J.J.</given-names></name></person-group><article-title>Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials</article-title><source>Clin Pharmacokinet</source><volume>37</volume><year>1999</year><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-199937010-00001</pub-id><pub-id pub-id-type="pmid">10451780</pub-id></element-citation></ref><ref id="bib141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Craig</surname><given-names>W.A.</given-names></name></person-group><article-title>Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men</article-title><source>Clin Infect Dis</source><volume>26</volume><year>1998</year><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">9455502</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/516284</pub-id></element-citation></ref><ref id="bib142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marchbanks</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>McKiel</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>D.H.</given-names></name><name name-style="western"><surname>Robillard</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Painter</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zinner</surname><given-names>S.H.</given-names></name></person-group><article-title>Dose ranging and fractionation of intravenous ciprofloxacin against <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Staphylococcus aureus</italic> in a <italic toggle="yes">in vitro</italic> model of infection</article-title><source>Antimicrob Agents Chemother</source><volume>37</volume><year>1993</year><fpage>1756</fpage><lpage>1763</lpage><pub-id pub-id-type="pmid">8239581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.37.9.1756</pub-id><pub-id pub-id-type="pmcid">PMC188066</pub-id></element-citation></ref><ref id="bib143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madaras-Kelly</surname><given-names>K.J.</given-names></name><name name-style="western"><surname>Ostergaard</surname><given-names>B.E.</given-names></name><name name-style="western"><surname>Hovde</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Rotschafer</surname><given-names>J.C.</given-names></name></person-group><article-title>Twentyfour-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of <italic toggle="yes">Pseudomonas aeruginosa</italic> and an <italic toggle="yes">in vitro</italic> pharmacodynamic model</article-title><source>Antimicrob Agents Chemother</source><volume>40</volume><year>1996</year><fpage>627</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">8851583</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.40.3.627</pub-id><pub-id pub-id-type="pmcid">PMC163170</pub-id></element-citation></ref><ref id="bib144"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.Y.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.W.</given-names></name><name name-style="western"><surname>Raymond</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ling</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>A.F.B.</given-names></name></person-group><article-title>Antibiotic exposure and its relationship to postantibiotic effect and bactericidal activity: constant versus exponentially decreasing tobramycin concentrations against <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Antimicrob Agents Chemother</source><volume>41</volume><year>1997</year><fpage>1808</fpage><lpage>1811</lpage><pub-id pub-id-type="pmid">9257767</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.41.8.1808</pub-id><pub-id pub-id-type="pmcid">PMC164011</pub-id></element-citation></ref><ref id="bib145"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouvier d&#8217;Yvoire</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Maire</surname><given-names>P.H.</given-names></name></person-group><article-title>Dosage regimens of antibacterials: implications of a pharmacokinetic/pharmacodynamic model</article-title><source>Clin Drug Invest</source><volume>11</volume><year>1996</year><fpage>229</fpage><lpage>239</lpage></element-citation></ref><ref id="bib146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lipman</surname><given-names>J.</given-names></name><name name-style="western"><surname>Gomersall</surname><given-names>C.D.</given-names></name><name name-style="western"><surname>Gin</surname><given-names>T.</given-names></name><name name-style="western"><surname>Joynt</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Young</surname><given-names>R.J.</given-names></name></person-group><article-title>Continuous infusion ceftazidime in intensive care: a randomized controlled trial</article-title><source>J Antimicrob Chemother</source><volume>43</volume><year>1999</year><fpage>309</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">11252342</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/43.2.309</pub-id></element-citation></ref><ref id="bib147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manduru</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mihm</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>White</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Friedrich</surname><given-names>L.V.</given-names></name><name name-style="western"><surname>Flume</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Bosso</surname><given-names>J.A.</given-names></name></person-group><article-title><italic toggle="yes">In vitro</italic> pharmacodynamics of ceftazidime against <italic toggle="yes">Pseudomonas aeruginosa</italic> isolates from cystic fibrosis patients</article-title><source>Antimicrob Agents Chemother</source><volume>41</volume><year>1997</year><fpage>2053</fpage><lpage>2056</lpage><pub-id pub-id-type="pmid">9303416</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.41.9.2053</pub-id><pub-id pub-id-type="pmcid">PMC164067</pub-id></element-citation></ref><ref id="bib148"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>J.Q.</given-names></name><name name-style="western"><surname>Ballow</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Forrest</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hyatt</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Sands</surname><given-names>M.F.</given-names></name><name name-style="western"><surname>Peloquin</surname><given-names>C.A.</given-names></name></person-group><article-title>Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables</article-title><source>J Antimicrob Chemother</source><volume>45</volume><year>2000</year><fpage>9</fpage><lpage>17</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/45.suppl_2.9</pub-id><pub-id pub-id-type="pmid">10719007</pub-id></element-citation></ref><ref id="bib149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Permin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Christensen</surname><given-names>H.O.</given-names></name><name name-style="western"><surname>Moller</surname><given-names>A.F.</given-names></name><name name-style="western"><surname>Moller</surname><given-names>S.</given-names></name></person-group><article-title>Ceftazidime treatment of chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> respiratory tract infection in cystic fibrosis</article-title><source>J Antimicrob Chemother</source><volume>12</volume><issue>Suppl A</issue><year>1983</year><fpage>313</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">6352636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/12.suppl_a.313</pub-id></element-citation></ref><ref id="bib150"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gold</surname><given-names>R.</given-names></name><name name-style="western"><surname>Overmeyer</surname><given-names>A.</given-names></name><name name-style="western"><surname>Knie</surname><given-names>B.</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>P.C.</given-names></name><name name-style="western"><surname>Levison</surname><given-names>H.</given-names></name></person-group><article-title>Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis</article-title><source>Pediatr Infect Dis</source><volume>4</volume><year>1985</year><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">3885181</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00006454-198503000-00012</pub-id></element-citation></ref><ref id="bib151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stenvang Pedersen</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pressler</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Friis- Moller</surname><given-names>A.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name></person-group><article-title>Immediate and prolonged clinical efficacy of ceftazidime versus ceftazidime plus tobramycin in chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> infection in cystic fibrosis</article-title><source>Scand J Infect Dis</source><volume>18</volume><year>1986</year><fpage>133</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">3518048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/00365548609032319</pub-id></element-citation></ref><ref id="bib152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Padoan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Cambisano</surname><given-names>W.</given-names></name><name name-style="western"><surname>Costantini</surname><given-names>D.</given-names></name><name name-style="western"><surname>Crossignani</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Danza</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Trezzi</surname><given-names>G.</given-names></name></person-group><article-title>Ceftazidime monotherapy vs. combined therapy in <italic toggle="yes">Pseudomonas</italic> pulmonary infections in cystic fibrosis</article-title><source>Pediatr Infect Dis J</source><volume>6</volume><year>1987</year><fpage>648</fpage><lpage>653</lpage><pub-id pub-id-type="pmid">3302917</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00006454-198707000-00006</pub-id></element-citation></ref><ref id="bib153"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Craig</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Ebert</surname><given-names>S.C.</given-names></name></person-group><article-title>Continuous infusion of beta-lactam antibiotics</article-title><source>Antimicrob Agents Chemother</source><volume>36</volume><year>1992</year><fpage>2577</fpage><lpage>2583</lpage><pub-id pub-id-type="pmid">1482127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/aac.36.12.2577</pub-id><pub-id pub-id-type="pmcid">PMC245510</pub-id></element-citation></ref><ref id="bib154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mouton</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Vinks</surname><given-names>A.A.</given-names></name></person-group><article-title>Is continuous infusion of beta-lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations</article-title><source>J Antimicrob Chemother</source><volume>38</volume><year>1996</year><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">8858451</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/38.1.5</pub-id></element-citation></ref><ref id="bib155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byl</surname><given-names>B.</given-names></name><name name-style="western"><surname>Baran</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>F.</given-names></name><name name-style="western"><surname>Herschuelz</surname><given-names>A.</given-names></name><name name-style="western"><surname>Thys</surname><given-names>J.P.</given-names></name></person-group><article-title>Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients</article-title><source>J Antimicrob Chemother</source><volume>48</volume><year>2001</year><fpage>325</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">11481316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/48.2.325</pub-id></element-citation></ref><ref id="bib156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rougier</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ducher</surname><given-names>M.</given-names></name><name name-style="western"><surname>Maurin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Corvaisier</surname><given-names>S.</given-names></name><name name-style="western"><surname>Claude</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jelliffe</surname><given-names>R.</given-names></name></person-group><article-title>Aminoglycoside dosages and nephrotoxicity: quantitative relationships</article-title><source>Clin Pharmacokinet</source><volume>42</volume><year>2003</year><fpage>493</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">12739987</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-200342050-00007</pub-id></element-citation></ref><ref id="bib157"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenfeld</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>B.</given-names></name></person-group><article-title>Aerosolized antibiotics for bacterial lower airway infections: principles, efficacy, and pitfalls</article-title><source>Infect Dis Clin Pract</source><volume>7</volume><year>1998</year><fpage>66</fpage><lpage>79</lpage></element-citation></ref><ref id="bib158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beasley</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fishwick</surname><given-names>D.</given-names></name><name name-style="western"><surname>Miles</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>Hendeles</surname><given-names>L.</given-names></name></person-group><article-title>Preservatives in nebulizer solutions: risks without benefit</article-title><source>Pharmacotherapy</source><volume>18</volume><year>1998</year><fpage>130</fpage><lpage>139</lpage><pub-id pub-id-type="pmid">9469687</pub-id></element-citation></ref><ref id="bib159"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klepser</surname><given-names>M.E.</given-names></name></person-group><article-title>Role of nebulized antibiotics for the treatment of respiratory infections</article-title><source>Curr Opin Infect Dis</source><volume>17</volume><year>2004</year><fpage>109</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">15021049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00001432-200404000-00007</pub-id></element-citation></ref><ref id="bib160"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Catchpole</surname><given-names>C.R.</given-names></name><name name-style="western"><surname>Andrews</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Brenwald</surname><given-names>N.</given-names></name><name name-style="western"><surname>Wise</surname><given-names>R.</given-names></name></person-group><article-title>A reassessment of the in-vitro activity of colistin sulphomethate sodium</article-title><source>J Antimicrob Chemother</source><volume>39</volume><year>1997</year><fpage>255</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">9069549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/39.2.255</pub-id></element-citation></ref><ref id="bib161"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bauldoff</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Nunley</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Manzetti</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Dauber</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Keenan</surname><given-names>R.J.</given-names></name></person-group><article-title>Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation</article-title><source>Transplantation</source><volume>64</volume><year>1997</year><fpage>748</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">9311714</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00007890-199709150-00015</pub-id></element-citation></ref><ref id="bib162"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frederiksen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Antibiotic treatment of initial colonization with <italic toggle="yes">Pseudomonas aeruginosa</italic> postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>23</volume><year>1997</year><fpage>330</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">9168506</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1099-0496(199705)23:5&lt;330::aid-ppul4&gt;3.0.co;2-o</pub-id></element-citation></ref><ref id="bib163"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Drlica</surname><given-names>K.</given-names></name></person-group><article-title>Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window</article-title><source>J Infect Dis</source><volume>185</volume><year>2002</year><fpage>561</fpage><lpage>565</lpage><pub-id pub-id-type="pmid">11865411</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/338571</pub-id></element-citation></ref><ref id="bib164"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kahlmeter</surname><given-names>G.</given-names></name></person-group><article-title>Gentamicin and tobramycin. Clinical pharmacokinetics and nephrotoxicity. Aspects on assay techniques</article-title><source>Scand J Infect Dis Suppl</source><volume>18</volume><year>1979</year><fpage>1</fpage><lpage>40</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/inf.1979.11.suppl-18.01</pub-id><pub-id pub-id-type="pmid">111346</pub-id></element-citation></ref><ref id="bib165"><label>165.</label><mixed-citation publication-type="other">Cant&#243;n R, Garc&#237;a-Castillo MC, Morosini MI, Baquero MR, Oliver A, Baquero F. Mutant prevention concentrations (MPCs) in mutator and non-mutator <italic toggle="yes">Pseudomonas aeruginosa</italic> populations from cystic fibrosis patients. 43th Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago 2003. Libro de res&#250;menes, resumen A-1320.</mixed-citation></ref><ref id="bib166"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LiPuma</surname><given-names>J.J.</given-names></name></person-group><article-title>Microbiological and immunologic considerations with aerosolized drug delivery</article-title><source>Chest</source><volume>120</volume><issue>Suppl 3</issue><year>2001</year><fpage>S118</fpage><lpage>S123</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.120.3_suppl.118s</pub-id><pub-id pub-id-type="pmid">11555566</pub-id></element-citation></ref><ref id="bib167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schulin</surname><given-names>T.</given-names></name></person-group><article-title>In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against <italic toggle="yes">Pseudomonas aeruginosa</italic> isolated from cystic fibrosis patients in southern Germany</article-title><source>J Antimicrob Chemother</source><volume>49</volume><year>2002</year><fpage>403</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">11815589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/49.2.403</pub-id></element-citation></ref><ref id="bib168"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cant&#243;n</surname><given-names>R.</given-names></name></person-group><article-title>Interpretaci&#243;n del antibiograma en la elecci&#243;n del antibi&#243;tico y v&#237;a de administraci&#243;n</article-title><source>Rev Clin Esp</source><volume>203</volume><year>2003</year><fpage>608</fpage><lpage>611</lpage><pub-id pub-id-type="pmid">14622515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1157/13053735</pub-id></element-citation></ref><ref id="bib169"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Van Dalfsen</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Shawar</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Otto</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Garber</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Quan</surname><given-names>J.M.</given-names></name></person-group><article-title>Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis</article-title><source>J Infect Dis</source><volume>179</volume><year>1999</year><fpage>1190</fpage><lpage>1196</lpage><pub-id pub-id-type="pmid">10191222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/314727</pub-id></element-citation></ref><ref id="bib170"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campbell</surname><given-names>P.W.</given-names><suffix>3rd</suffix></name><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name></person-group><article-title>Use of aerosolized antibiotics in patients with cystic fibrosis</article-title><source>Chest</source><volume>116</volume><year>1999</year><fpage>775</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">10492286</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.116.3.775</pub-id></element-citation></ref><ref id="bib171"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pedersen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Jensen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Flensborg</surname><given-names>E.W.</given-names></name></person-group><article-title>Management of <italic toggle="yes">Pseudomonas aeruginosa</italic> lung infection in Danish cystic fibrosis patients</article-title><source>Acta Paediatr Scand</source><volume>76</volume><year>1987</year><fpage>955</fpage><lpage>961</lpage><pub-id pub-id-type="pmid">3425313</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1651-2227.1987.tb17271.x</pub-id></element-citation></ref><ref id="bib172"><label>172.</label><mixed-citation publication-type="other">Cystic Fibrosis Trust Report of the UK Cystic Fibrosis Trust's Antibiotic Group: Antibiotic Treatment for Cystic Fibrosis. Cystic Fibrosis Trust; 2000.</mixed-citation></ref><ref id="bib173"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jensen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>C.H.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name></person-group><article-title>The efficacy and safety of ciprofloxacin and ofloxacin in chronic <italic toggle="yes">Pseudomonas aeruginosa</italic> infection in cystic fibrosis</article-title><source>J Antimicrob Chemother</source><volume>20</volume><year>1987</year><fpage>585</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">3479420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/20.4.585</pub-id></element-citation></ref><ref id="bib174"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jensen</surname><given-names>T.</given-names></name><name name-style="western"><surname>Pedersen</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Flensborg</surname><given-names>E.W.</given-names></name></person-group><article-title>Use of antibiotics in cystic fibrosis: the Danish approach</article-title><source>Antibiotic Chemother</source><volume>42</volume><year>1989</year><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">2688545</pub-id></element-citation></ref><ref id="bib175"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moss</surname><given-names>R.B.</given-names></name></person-group><article-title>Administration of aerosolized antibiotics in cystic fibrosis patients</article-title><source>Chest</source><volume>120</volume><issue>Suppl 3</issue><year>2001</year><fpage>S107</fpage><lpage>S113</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.120.3_suppl.107s</pub-id><pub-id pub-id-type="pmid">11555564</pub-id></element-citation></ref><ref id="bib176"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ball</surname><given-names>P.</given-names></name></person-group><article-title>Emergent resistance to ciprofloxacin among <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Staphylococcus aureus</italic>: clinical significance and therapeutic approaches</article-title><source>J Antimicrob Chemother</source><volume>26</volume><issue>Suppl F</issue><year>1990</year><fpage>165</fpage><lpage>179</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jac/26.suppl_f.165</pub-id><pub-id pub-id-type="pmid">2127272</pub-id></element-citation></ref><ref id="bib177"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cant&#243;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gir&#243;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mart&#237;nez-Mart&#237;nez</surname><given-names>L.</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sol&#233;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Valdezate</surname><given-names>S.</given-names></name></person-group><article-title>Pat&#243;genos multirresistentes en fibrosis qu&#237;stica</article-title><source>Arch Bronconeumol</source><volume>38</volume><year>2002</year><fpage>376</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">12199920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0300-2896(02)75243-5</pub-id></element-citation></ref><ref id="bib178"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Escribano</surname><given-names>A.</given-names></name></person-group><article-title>Diagn&#243;stico y tratamiento de la exacerbaci&#243;n infecciosa en la fibrosis qu&#237;stica</article-title><source>Arch Bronconeumol</source><volume>36</volume><year>2000</year><fpage>525</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">11116550</pub-id></element-citation></ref><ref id="bib179"><label>179.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Gartner</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cobos</surname><given-names>N.</given-names></name></person-group><chapter-title>Tratamiento de la enfermedad respiratoria en la fibrosis qu&#237;stica</chapter-title><person-group person-group-type="editor"><name name-style="western"><surname>Cobos</surname><given-names>N.</given-names></name><name name-style="western"><surname>P&#233;rez-Yarza</surname><given-names>E.G.</given-names></name></person-group><source>Tratado de neumolog&#237;a pedi&#225;trica</source><year>2003</year><publisher-name>Ergon</publisher-name><publisher-loc>Madrid</publisher-loc><fpage>717</fpage><lpage>730</lpage></element-citation></ref><ref id="bib180"><label>180.</label><mixed-citation publication-type="other">Grupo de Trabajo de la SEPAR. Normativa sobre diagn&#243;stico y tratamiento de la afecci&#243;n respiratoria en la fibrosis qu&#237;stica. En: SEPAR, editor. Recomendaciones SEPAR, 2001. N.&#176; 29. Barcelona: Ediciones Doyma; 2001.</mixed-citation></ref><ref id="bib181"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Grupo de trabajo Fibrosis Qu&#237;stica</collab></person-group><issue-title>Sociedad Espa&#241;ola de Neumolog&#237;a Pedi&#225;trica. Protocolo de diagn&#243;stico y seguimiento de los enfermos con fibrosis qu&#237;stica</issue-title><source>An Esp Pediatr</source><volume>50</volume><year>1999</year><fpage>625</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">10410431</pub-id></element-citation></ref><ref id="bib182"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#225;iz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Baranda</surname><given-names>F.</given-names></name><name name-style="western"><surname>Coll</surname><given-names>R.</given-names></name><name name-style="western"><surname>Prados</surname><given-names>C.</given-names></name><name name-style="western"><surname>Vendrell</surname><given-names>M.</given-names></name><name name-style="western"><surname>Escribano</surname><given-names>A.</given-names></name></person-group><article-title>Normativas SEPAR. Normativa del diagn&#243;stico y el tratamiento de la afecci&#243;n respiratoria en la Fibrosis Qu&#237;stica</article-title><source>Arch Bronconeumol</source><volume>37</volume><year>2001</year><fpage>316</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">11562317</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0300-2896(01)75101-0</pub-id></element-citation></ref><ref id="bib183"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vendrell</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Gracia</surname><given-names>J.</given-names></name></person-group><article-title>Antibioterapia inhalada</article-title><source>Arch Bronconeumol</source><volume>33</volume><year>1997</year><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">9072132</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0300-2896(15)30676-1</pub-id></element-citation></ref><ref id="bib184"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Conference de Consensus</collab></person-group><article-title>Prise en charge du patients attaint de mucoviscidose. Texte des recommandations (version courte) du th&#232;me 1 &#8220;pneumologie et infectologie&#8221;</article-title><source>Rev Mal Respir</source><volume>20</volume><year>2003</year><fpage>149</fpage><lpage>157</lpage></element-citation></ref><ref id="bib185"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Diagnosis and treatment of cystic fibrosis</article-title><source>Respiration</source><volume>67</volume><year>2000</year><fpage>239</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">10867591</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000029503</pub-id></element-citation></ref><ref id="bib186"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yankaskas</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Sufian</surname><given-names>B.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>R.H.</given-names></name><name name-style="western"><surname>Rodman</surname><given-names>D.</given-names></name></person-group><article-title>Cystic fibrosis adult care: consensus conference report</article-title><source>Chest</source><volume>125</volume><issue>1 Suppl</issue><year>2004</year><fpage>S1</fpage><lpage>S39</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.125.1_suppl.1s</pub-id><pub-id pub-id-type="pmid">14734689</pub-id></element-citation></ref><ref id="bib187"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Siegel</surname><given-names>J.</given-names></name></person-group><article-title>Cystic Fibrosis Foundation Consensus Conference on Infection Control Participants. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission</article-title><source>Am J Infect Control</source><volume>31</volume><issue>3 Suppl</issue><year>2003</year><fpage>S1</fpage><lpage>S62</lpage><pub-id pub-id-type="pmid">12762292</pub-id></element-citation></ref><ref id="bib188"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>V&#225;zquez</surname><given-names>C.</given-names></name><name name-style="western"><surname>Municio</surname><given-names>M.</given-names></name><name name-style="western"><surname>Corera</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gaztelurrutia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sojo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Vitoria</surname><given-names>J.C.</given-names></name></person-group><article-title>Early treatment of <italic toggle="yes">Pseudomonas aeruginosa</italic> colonization in cystic fibrosis</article-title><source>Acta Paediatr</source><volume>82</volume><year>1993</year><fpage>308</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">8495091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1651-2227.1993.tb12668.x</pub-id></element-citation></ref><ref id="bib189"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ratjen</surname><given-names>F.</given-names></name><name name-style="western"><surname>Comes</surname><given-names>G.</given-names></name><name name-style="western"><surname>Paul</surname><given-names>K.</given-names></name><name name-style="western"><surname>Posselt</surname><given-names>H.G.</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>T.O.</given-names></name><name name-style="western"><surname>Harms</surname><given-names>K.</given-names></name><collab>and the German Board of the European Registry for Cystic Fibrosis (ERCF)</collab></person-group><article-title>Effect of continuous antistaphylococcal therapy on the rate of <italic toggle="yes">P. aeruginosa</italic> acquisition in patients with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>31</volume><year>2001</year><fpage>13</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">11180669</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1099-0496(200101)31:1&lt;13::aid-ppul1001&gt;3.0.co;2-n</pub-id></element-citation></ref><ref id="bib190"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nixon</surname><given-names>G.M.</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>D.S.</given-names></name><name name-style="western"><surname>Carzino</surname><given-names>R.</given-names></name><name name-style="western"><surname>Carlin</surname><given-names>J.B.</given-names></name><name name-style="western"><surname>Olinsky</surname><given-names>A.</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>C.F.</given-names></name></person-group><article-title>Clinical outcome after early <italic toggle="yes">Pseudomonas aeruginosa</italic> infection in cystic fibrosis</article-title><source>J Pediatr</source><volume>138</volume><year>2001</year><fpage>699</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">11343046</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mpd.2001.112897</pub-id></element-citation></ref><ref id="bib191"><label>191.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Wainwright</surname><given-names>C.</given-names></name></person-group><chapter-title>Early infection with <italic toggle="yes">Pseudomonas aeruginosa</italic> can be cleared in young children with cystic fibrosis</chapter-title><year>2002</year><publisher-name>North American Cystic Fibrosis Conference</publisher-name><publisher-loc>New Orleans</publisher-loc></element-citation></ref><ref id="bib192"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>K.H.</given-names></name><name name-style="western"><surname>Mulheran</surname><given-names>M.</given-names></name><name name-style="western"><surname>Knox</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Smyth</surname><given-names>A.R.</given-names></name></person-group><article-title>Aminoglycoside prescribing and surveillance in cystic fibrosis</article-title><source>Am J Respir Crit Care Med</source><volume>167</volume><year>2003</year><fpage>819</fpage><lpage>823</lpage><pub-id pub-id-type="pmid">12623858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.200109-012CC</pub-id></element-citation></ref><ref id="bib193"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryan</surname><given-names>G.</given-names></name><name name-style="western"><surname>Mukhopadhyay</surname><given-names>S.</given-names></name><name name-style="western"><surname>Singh</surname><given-names>M.</given-names></name></person-group><article-title>Nebulised anti-pseudomonal antibiotics for cystic fibrosis</article-title><source>Cochrane Database Syst Rev</source><year>2003</year><fpage>CD001021</fpage><pub-id pub-id-type="pmid">12917897</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD001021</pub-id></element-citation></ref><ref id="bib194"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodson</surname><given-names>M.E.</given-names></name></person-group><article-title>Treatment of cystic fibrosis in the adult</article-title><source>Respiration</source><volume>67</volume><year>2000</year><fpage>595</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">11124641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000056287</pub-id></element-citation></ref><ref id="bib195"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ledson</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Gallagher</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Cowperthwaite</surname><given-names>C.</given-names></name><name name-style="western"><surname>Convery</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Walshaw</surname><given-names>M.J.</given-names></name></person-group><article-title>Four years&#8217; experience of intravenous colomycin in an adult cystic fibrosis unit</article-title><source>Eur Respir J</source><volume>12</volume><year>1998</year><fpage>592</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">9762785</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/09031936.98.12030592</pub-id></element-citation></ref><ref id="bib196"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frederiksen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lanng</surname><given-names>S.</given-names></name><name name-style="western"><surname>Koch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment</article-title><source>Pediatric Pulmunol</source><volume>21</volume><year>1996</year><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1099-0496(199603)21:3&lt;153::AID-PPUL1&gt;3.0.CO;2-R</pub-id><pub-id pub-id-type="pmid">8860069</pub-id></element-citation></ref><ref id="bib197"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Redding</surname><given-names>G.</given-names></name><name name-style="western"><surname>Doershuk</surname><given-names>C.</given-names></name><name name-style="western"><surname>Golman</surname><given-names>D.</given-names></name><name name-style="western"><surname>Gore</surname><given-names>E.</given-names></name><name name-style="western"><surname>Hilman</surname><given-names>B.</given-names></name></person-group><article-title>Sputum changes associated with therapy for endobronchial exacerbations in cystic fibrosis</article-title><source>J Pediatr</source><volume>112</volume><year>1988</year><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">3127569</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-3476(88)80165-3</pub-id></element-citation></ref><ref id="bib198"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Regelman</surname><given-names>W.E.</given-names></name><name name-style="western"><surname>Elliot</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Warwick</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Clawson</surname><given-names>C.C.</given-names></name></person-group><article-title>Reduction of sputum <italic toggle="yes">Pseudomonas aeruginosa</italic> density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone</article-title><source>Am Rev Respir Dis</source><volume>141</volume><year>1990</year><fpage>914</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">2109558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/ajrccm/141.4_Pt_1.914</pub-id></element-citation></ref><ref id="bib199"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marshal</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Samuelson</surname><given-names>W.M.</given-names></name></person-group><article-title>Basic therapies in cystic fibrosis: does standard therapy work?</article-title><source>Clin Chest Med</source><volume>19</volume><year>1989</year><fpage>487</fpage><lpage>504</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0272-5231(05)70095-2</pub-id><pub-id pub-id-type="pmid">9759551</pub-id></element-citation></ref><ref id="bib200"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolter</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Bowler</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Nolan</surname><given-names>P.J.</given-names></name><name name-style="western"><surname>McCormack</surname><given-names>J.G.</given-names></name></person-group><article-title>Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects</article-title><source>Eur Respir J</source><volume>10</volume><year>1997</year><fpage>896</fpage><lpage>900</lpage><pub-id pub-id-type="pmid">9150331</pub-id></element-citation></ref><ref id="bib201"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marco</surname><given-names>T.</given-names></name><name name-style="western"><surname>Asensio</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bosque</surname><given-names>M.</given-names></name><name name-style="western"><surname>De Gracia</surname><given-names>J.</given-names></name><name name-style="western"><surname>Serra</surname><given-names>C.</given-names></name></person-group><article-title>Home intravenous antibiotics for cystic fibrosis</article-title><source>Cochrane Database Syst Rev</source><year>2000</year><comment>CD001917</comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/14651858.CD001917</pub-id><pub-id pub-id-type="pmid">11034733</pub-id></element-citation></ref><ref id="bib202"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gir&#243;n</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>A.</given-names></name><name name-style="western"><surname>M&#225;iz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Salcedo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Beltr&#225;n</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>M.T.</given-names></name></person-group><article-title>Tratamiento antibi&#243;tico intravenoso domiciliario en las unidades de fibrosis qu&#237;stica de la Comunidad de Madrid</article-title><source>Med Clin (Barc)</source><volume>122</volume><year>2004</year><fpage>648</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">15153343</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0025-7753(04)74341-9</pub-id></element-citation></ref><ref id="bib203"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kudoh</surname><given-names>S.</given-names></name><name name-style="western"><surname>Uetake</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hagiwara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Hirayama</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hus</surname><given-names>L.H.</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>H.</given-names></name></person-group><article-title>Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis</article-title><source>Nihon Kyobu Shikkan Gakkai Zasshi</source><volume>25</volume><year>1987</year><fpage>632</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">3682440</pub-id></element-citation></ref><ref id="bib204"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Homma</surname><given-names>H.</given-names></name><name name-style="western"><surname>Yamanaka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tanimoto</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tamura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chijimatsu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Kira</surname><given-names>S.</given-names></name></person-group><article-title>Diffuse panbronchiolitis. A disease of the transitional zone of the lung</article-title><source>Chest</source><volume>83</volume><year>1983</year><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">6848335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.83.1.63</pub-id></element-citation></ref><ref id="bib205"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawrence</surname><given-names>D.</given-names></name></person-group><article-title>Clues to mechanism of <italic toggle="yes">Pseudomonas</italic> resistance in cystic fibrosis</article-title><source>Lancet</source><volume>359</volume><year>2002</year><fpage>1410</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(02)08394-0</pub-id><pub-id pub-id-type="pmid">11978345</pub-id></element-citation></ref><ref id="bib206"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaylor</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Reilly</surname><given-names>J.C.</given-names></name></person-group><article-title>Therapy with macrolides in patients with cystic fibrosis</article-title><source>Pharmacotherapy</source><volume>22</volume><year>2002</year><fpage>227</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">11837560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1592/phco.22.3.227.33544</pub-id></element-citation></ref><ref id="bib207"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>M&#225;iz</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cant&#243;n</surname><given-names>R.</given-names></name></person-group><article-title>Tratamiento con azitromicina en la fibrosis qu&#237;stica</article-title><source>Med Clin (Barc)</source><volume>122</volume><year>2004</year><fpage>311</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">15030744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0025-7753(04)74217-7</pub-id></element-citation></ref><ref id="bib208"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolter</surname><given-names>J.</given-names></name><name name-style="western"><surname>Seeney</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bell</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bowler</surname><given-names>S.</given-names></name><name name-style="western"><surname>Masel</surname><given-names>P.</given-names></name><name name-style="western"><surname>McCormack</surname><given-names>J.</given-names></name></person-group><article-title>Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial</article-title><source>Thorax</source><volume>57</volume><year>2002</year><fpage>212</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">11867823</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thorax.57.3.212</pub-id><pub-id pub-id-type="pmcid">PMC1746273</pub-id></element-citation></ref><ref id="bib209"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Equi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Balfour-Lynn</surname><given-names>I.M.</given-names></name><name name-style="western"><surname>Bush</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rosenthal</surname><given-names>M.</given-names></name></person-group><article-title>Long term azithromycin in children with cystic fibrosis: a randomised, placebo- controlled crossover trial</article-title><source>Lancet</source><volume>360</volume><year>2002</year><fpage>978</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">12383667</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0140-6736(02)11081-6</pub-id></element-citation></ref><ref id="bib210"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>B.C.</given-names></name><name name-style="western"><surname>Mayer-Hamblett</surname><given-names>N.</given-names></name><name name-style="western"><surname>Burns</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Quittner</surname><given-names>A.L.</given-names></name><name name-style="western"><surname>Cibene</surname><given-names>D.A.</given-names></name><collab>Macrolide Study Group</collab></person-group><article-title>Azithromycin in patients with cystic fibrosis chronically infected with <italic toggle="yes">Pseudomonas aeruginosa</italic>: a randomized controlled trial</article-title><source>JAMA</source><volume>290</volume><year>2003</year><fpage>1749</fpage><lpage>1756</lpage><pub-id pub-id-type="pmid">14519709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.290.13.1749</pub-id></element-citation></ref><ref id="bib211"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Gabriel</surname><given-names>P.S.</given-names></name><name name-style="western"><surname>Knirsch</surname><given-names>C.</given-names></name></person-group><article-title>Synergistic activities of macrolide antibiotics against <italic toggle="yes">Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia</italic>, and <italic toggle="yes">Alcaligenes xylosoxidans</italic> isolated from patients with cystic fibrosis</article-title><source>Antimicrob Agents Chemother</source><volume>46</volume><year>2002</year><fpage>1105</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">11897598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.46.4.1105-1107.2002</pub-id><pub-id pub-id-type="pmcid">PMC127106</pub-id></element-citation></ref><ref id="bib212"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peckham</surname><given-names>D.G.</given-names></name></person-group><article-title>Macrolide antibiotics and cystic fibrosis</article-title><source>Thorax</source><volume>57</volume><year>2002</year><fpage>189</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">11867820</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thorax.57.3.189</pub-id><pub-id pub-id-type="pmcid">PMC1746280</pub-id></element-citation></ref><ref id="bib213"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wales</surname><given-names>D.</given-names></name><name name-style="western"><surname>Woodhead</surname><given-names>M.</given-names></name></person-group><article-title>Anti-inflammatory effects of macrolides</article-title><source>Thorax</source><volume>54</volume><issue>Suppl 2</issue><year>1999</year><fpage>S58</fpage><lpage>S62</lpage><pub-id pub-id-type="pmid">10451695</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.54.2008.s58</pub-id><pub-id pub-id-type="pmcid">PMC1765933</pub-id></element-citation></ref><ref id="bib214"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tateda</surname><given-names>K.</given-names></name><name name-style="western"><surname>Comte</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pechere</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Kohler</surname><given-names>T.</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>K.</given-names></name><name name-style="western"><surname>Van Delden</surname><given-names>C.</given-names></name></person-group><article-title>Azithromycin inhibits quorum sensing in <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Antimicrob Agents Chemother</source><volume>45</volume><year>2001</year><fpage>1930</fpage><lpage>1933</lpage><pub-id pub-id-type="pmid">11353657</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/AAC.45.6.1930-1933.2001</pub-id><pub-id pub-id-type="pmcid">PMC90577</pub-id></element-citation></ref><ref id="bib215"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beringer</surname><given-names>P.M.</given-names></name><name name-style="western"><surname>Appleman</surname><given-names>M.D.</given-names></name></person-group><article-title>Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features</article-title><source>Curr Op Pulm Med</source><volume>6</volume><year>2000</year><fpage>545</fpage><lpage>550</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00063198-200011000-00015</pub-id><pub-id pub-id-type="pmid">11100967</pub-id></element-citation></ref><ref id="bib216"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballmann</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rabsch</surname><given-names>P.</given-names></name><name name-style="western"><surname>Von der Hardt</surname><given-names>H.</given-names></name></person-group><article-title>Long term follow up changes in FEV<sub>1</sub> and treatment intensity during <italic toggle="yes">Pseudomonas aeruginosa</italic> colonization in patients with cystic fibrosis</article-title><source>Thorax</source><volume>53</volume><year>1998</year><fpage>732</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">10319054</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.53.9.732</pub-id><pub-id pub-id-type="pmcid">PMC1745320</pub-id></element-citation></ref><ref id="bib217"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S.S.</given-names></name><name name-style="western"><surname>FitzSimmons</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>O&#8217;Leary</surname><given-names>L.A.</given-names></name><name name-style="western"><surname>Rock</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Gwinn</surname><given-names>M.L.</given-names></name><name name-style="western"><surname>Khoury</surname><given-names>M.J.</given-names></name></person-group><article-title>Early diagnosis of cystic fibrosis in the newborn period and risk of <italic toggle="yes">Pseudomonas aeruginosa</italic> acquisition in the first 10 years of life: a registry-based longitudinal study</article-title><source>Pediatrics</source><volume>107</volume><year>2001</year><fpage>274</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">11158458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.107.2.274</pub-id></element-citation></ref><ref id="bib218"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saiman</surname><given-names>L.</given-names></name></person-group><article-title>Microbiology of early CF lung disease</article-title><source>Paediatr Respir Rev</source><volume>5</volume><issue>Suppl A</issue><year>2004</year><fpage>S367</fpage><lpage>S369</lpage><pub-id pub-id-type="pmid">14980298</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1526-0542(04)90065-6</pub-id></element-citation></ref><ref id="bib219"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Long</surname><given-names>F.F.</given-names></name><name name-style="western"><surname>Castile</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Brody</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Flucke</surname><given-names>R.L.</given-names></name><name name-style="western"><surname>Filbrun</surname><given-names>D.A.</given-names></name></person-group><article-title>Lungs in infants and young children: improved thin section CT with noninvasive controlled-ventilation techniqueinitial experience</article-title><source>Radiology</source><volume>212</volume><year>1999</year><fpage>588</fpage><lpage>593</lpage><pub-id pub-id-type="pmid">10429722</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiology.212.2.r99au06588</pub-id></element-citation></ref><ref id="bib220"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Castile</surname><given-names>R.G.</given-names></name><name name-style="western"><surname>Filbrun</surname><given-names>D.</given-names></name><name name-style="western"><surname>Flucke</surname><given-names>R.</given-names></name><name name-style="western"><surname>Frankline</surname><given-names>W.</given-names></name><name name-style="western"><surname>McCoy</surname><given-names>K.</given-names></name></person-group><article-title>Adult type pulmonary function tests in infants without respiratory diseases</article-title><source>Pediatr Pulmonol</source><volume>30</volume><year>2000</year><fpage>215</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">10973040</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1099-0496(200009)30:3&lt;215::aid-ppul6&gt;3.0.co;2-v</pub-id></element-citation></ref><ref id="bib221"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Turner</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Lanteri</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>LeSouef</surname><given-names>P.N.</given-names></name><name name-style="western"><surname>Sly</surname><given-names>P.D.</given-names></name></person-group><article-title>Improved detection of abnormal respiratory function using forced expiration from raised lung volume in infants with cystic fibrosis</article-title><source>Eur Respir J</source><volume>7</volume><year>1994</year><fpage>1995</fpage><lpage>1999</lpage><pub-id pub-id-type="pmid">7875271</pub-id></element-citation></ref><ref id="bib222"><label>222.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antuni</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Kharitonov</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>D.</given-names></name><name name-style="western"><surname>Hodson</surname><given-names>M.E.</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>P.J.</given-names></name></person-group><article-title>Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis</article-title><source>Thorax</source><volume>55</volume><year>2000</year><fpage>138</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">10639532</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thorax.55.2.138</pub-id><pub-id pub-id-type="pmcid">PMC1745687</pub-id></element-citation></ref><ref id="bib223"><label>223.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kerem</surname><given-names>E.</given-names></name><name name-style="western"><surname>Reisman</surname><given-names>J.</given-names></name><name name-style="western"><surname>Corey</surname><given-names>M.</given-names></name><name name-style="western"><surname>Canny</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Levison</surname><given-names>H.</given-names></name></person-group><article-title>Prediction of mortality in patients with cystic fibrosis</article-title><source>N Engl J Med</source><volume>326</volume><year>1992</year><fpage>1187</fpage><lpage>1191</lpage><pub-id pub-id-type="pmid">1285737</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM199204303261804</pub-id></element-citation></ref><ref id="bib224"><label>224.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pamukcu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bush</surname><given-names>A.</given-names></name><name name-style="western"><surname>Buchdahl</surname><given-names>R.</given-names></name></person-group><article-title>Effects of <italic toggle="yes">Pseudomonas aeruginosa</italic> colonization on lung function and anthropometric variables in children with cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>19</volume><year>1995</year><fpage>10</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">7675552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.1950190103</pub-id></element-citation></ref><ref id="bib225"><label>225.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steinkamp</surname><given-names>G.</given-names></name><name name-style="western"><surname>T&#252;mmler</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Malottke</surname><given-names>R.</given-names></name><name name-style="western"><surname>Von der Hardt</surname><given-names>U.</given-names></name></person-group><article-title>Treatment of <italic toggle="yes">Pseudomonas</italic> colonisation in cystic fibrosis</article-title><source>Arch Dis Chile</source><volume>64</volume><year>1988</year><fpage>1022</fpage><lpage>1028</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/adc.64.7.1022</pub-id><pub-id pub-id-type="pmcid">PMC1792706</pub-id><pub-id pub-id-type="pmid">2517000</pub-id></element-citation></ref><ref id="bib226"><label>226.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milla</surname><given-names>C.E.</given-names></name><name name-style="western"><surname>Warwick</surname><given-names>W.J.</given-names></name></person-group><article-title>Risk of death in cystic fibrosis patients with severely compromised lung function</article-title><source>Chest</source><volume>113</volume><year>1998</year><fpage>1230</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">9596299</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1378/chest.113.5.1230</pub-id></element-citation></ref><ref id="bib227"><label>227.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gappa</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ranganathan</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>Stocks</surname><given-names>J.</given-names></name></person-group><article-title>Lung function testing in infants with cystic fibrosis: lessons from the past and future directions</article-title><source>Pediatr Pulmonol</source><volume>32</volume><year>2001</year><fpage>228</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">11536453</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ppul.1113</pub-id></element-citation></ref><ref id="bib228"><label>228.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Thoracic Society/European Respiratory Society</collab></person-group><article-title>Respiratory mechanics in infants: physiologic evaluation in health and disease</article-title><source>Am Rev Resp Dis</source><volume>147</volume><year>1993</year><fpage>474</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">8430975</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/ajrccm/147.2.474</pub-id></element-citation></ref><ref id="bib229"><label>229.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orenstein</surname><given-names>D.M.</given-names></name></person-group><article-title>Exercise testing in cystic fibrosis</article-title><source>Pediatr Pulmonol</source><volume>25</volume><year>1998</year><fpage>223</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">9590481</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1099-0496(199804)25:4&lt;223::aid-ppul1&gt;3.0.co;2-l</pub-id></element-citation></ref><ref id="bib230"><label>230.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jorquera</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Salcedo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Villa</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Gir&#243;n</surname><given-names>R.M.</given-names></name><name name-style="western"><surname>Neira</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Sequeiros</surname><given-names>A.</given-names></name></person-group><article-title>Reproductibilidad del test de la marcha (walking test) en pacientes afectos de fibrosis qu&#237;stica</article-title><source>An Esp Ped</source><volume>51</volume><year>1999</year><fpage>475</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">10652797</pub-id></element-citation></ref><ref id="bib231"><label>231.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Da Silva Filho</surname><given-names>L.V.</given-names></name><name name-style="western"><surname>Levi</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Bento</surname><given-names>C.N.</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Da Silvo Ramos</surname><given-names>S.R.</given-names></name></person-group><article-title>Molecular epidemiology of <italic toggle="yes">Pseudomonas aeruginosa</italic> infections in a cystic fibrosis outpatient clinic</article-title><source>J Med Microbiol</source><volume>50</volume><year>2001</year><fpage>261</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">11232773</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1099/0022-1317-50-3-261</pub-id></element-citation></ref><ref id="bib232"><label>232.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spencker</surname><given-names>F.B.</given-names></name><name name-style="western"><surname>Haupt</surname><given-names>S.</given-names></name><name name-style="western"><surname>Claros</surname><given-names>M.C.</given-names></name><name name-style="western"><surname>Walter</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lietz</surname><given-names>T.</given-names></name><name name-style="western"><surname>Schille</surname><given-names>R.</given-names></name></person-group><article-title>Epidemiologic characterization of <italic toggle="yes">Pseudomonas aeruginosa</italic> in patients with cystic fibrosis</article-title><source>Clin Microbiol Infect</source><volume>6</volume><year>2000</year><fpage>600</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">11168063</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1469-0691.2000.00171.x</pub-id></element-citation></ref><ref id="bib233"><label>233.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLaughlin</surname><given-names>F.J.</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>W.J.</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Strieder</surname><given-names>D.J.</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>B.</given-names></name><name name-style="western"><surname>Taneja</surname><given-names>A.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>P.</given-names></name></person-group><article-title>Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillinplacebo</article-title><source>J Infect Dis</source><volume>147</volume><year>1983</year><fpage>559</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">6339649</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/infdis/147.3.559</pub-id></element-citation></ref><ref id="bib234"><label>234.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johansen</surname><given-names>H.K.</given-names></name><name name-style="western"><surname>Hoiby</surname><given-names>N.</given-names></name></person-group><article-title>Seasonal onset of initial colonization and chronic infection with <italic toggle="yes">Pseudomonas aeruginosa</italic> in patients with cystic fibrosis</article-title><source>Thorax</source><volume>47</volume><year>1992</year><fpage>109</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">1549817</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/thx.47.2.109</pub-id><pub-id pub-id-type="pmcid">PMC463585</pub-id></element-citation></ref><ref id="bib235"><label>235.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santamaria</surname><given-names>F.</given-names></name><name name-style="western"><surname>Grillo</surname><given-names>G.</given-names></name><name name-style="western"><surname>Guidi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Rotondo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Raia</surname><given-names>V.</given-names></name><name name-style="western"><surname>De Ritis</surname><given-names>G.</given-names></name></person-group><article-title>Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained?</article-title><source>Pediatrics</source><volume>101</volume><year>1998</year><fpage>908</fpage><lpage>913</lpage><pub-id pub-id-type="pmid">9565424</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.101.5.908</pub-id></element-citation></ref><ref id="bib236"><label>236.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brody</surname><given-names>A.S.</given-names></name></person-group><article-title>Cystic fibrosis: when should high-resolution computed tomography of the chest should be obtained?</article-title><source>Pediatrics</source><volume>101</volume><year>1998</year><fpage>1071</fpage><pub-id pub-id-type="pmid">9606238</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.101.6.1071</pub-id></element-citation></ref><ref id="bib237"><label>237.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaffe</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hamutcu</surname><given-names>R.</given-names></name><name name-style="western"><surname>Dhawan</surname><given-names>R.T.</given-names></name><name name-style="western"><surname>Adler</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rosenthal</surname><given-names>M.</given-names></name><name name-style="western"><surname>Bush</surname><given-names>A.</given-names></name></person-group><article-title>Routine ventilation scans in children with cystic fibrosis: diagnostic usefulness and prognostic value</article-title><source>Eur J Nucl Med</source><volume>28</volume><year>2001</year><fpage>1313</fpage><lpage>1318</lpage><pub-id pub-id-type="pmid">11585289</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002590100573</pub-id></element-citation></ref><ref id="bib238"><label>238.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rutala</surname><given-names>W.A.</given-names></name><name name-style="western"><surname>Weber</surname><given-names>D.J.</given-names></name></person-group><article-title>Disinfection and sterilization in health care facilities: what clinicians need to know</article-title><source>Clin Infect Dis</source><volume>39</volume><year>2004</year><fpage>702</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">15356786</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1086/423182</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>